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6ABSTRACT
ABSTRACT
Background. Posterior urethral valves (PUV) constitute the most common 
infravesical urinary obstruction in boys. PUV are often accompanied by severe 
consequences to the lower and upper urinary tract (LUT, UUT). They also 
represent a major urological cause for paediatric renal transplantations.  Surgical 
options for primary management invariably aim at abolition of valves. However, 
temporary urinary diversion may sometimes be a viable alternative, especially in 
critically ill patients or preterm infants. Since no previous systemically analysed 
true	long-term	studies	exist,	early	findings,	treatment	and	their	relations	to	late	
renal	function	are	not	clarified	in	many	respects.
Aims. The clinical characteristics and renal outcomes of PUV were assessed. 
Also evaluated were the risk factors for the progression to end-stage renal disease 
(ESRD).
Patients and methods. All patients treated for PUV at Children’s Hospital, 
University	of	Helsinki,	from	1953	to	2003	were	identified	from	the	hospital	
database. Age and mode of presentation, structural abnormalities, treatment, 
follow-up data and outcome were registered. In addition, the Finnish Kidney 
Transplantation Registry and the Finnish Population Register were reviewed to 
identify those who had progression to dialysis or renal transplantation or had 
demised.
Results. The diagnosis of PUV was made in 200 patients. Of all patients, 28 
(14%) had a prenatal diagnosis. Cryptorchidism was found in 31 patients (16%) 
and inguinal hernia in 21 patients (11%). These two disorders were associated 
with more severe forms of PUV. 
Urinoma was detected in 17 patients (9%). After onset of routine ultrasound 
(US) studies, the incidence was 15%.  Of the 17 patients, 9 had perirenal urinoma, 
6	urinary	ascites	and	2	urinothorax.	At	presentation	and	during	follow-up,	median	
creatinine	values	did	not	differ	significantly	between	patients	with	and	without	
urinoma or between cases with perirenal urinoma and those with urine ascites. 
In the group of 25 infant PUV patients, cystometric bladder capacity (CBC) 
was	a	median	of	22	ml	(range	5	to	125)	and	maximal	detrusor	pressure	during	
voiding	(Pmax	det)	112	cm	H2O (range 40 to 331). However, according to previous 
reports	maximal	voiding	pressures	were	similar	in	an	institutional	control	group	
and in male infant groups with different aetiologies. In our study, no correlation 
between high voiding pressures and poor primary kidney function was observed. 
7A	significant	increase	in	CBC	and	a	decrease	in	Pmax	det	were	registered	at	the	
one-year follow-up. 
Vesicoureteral	reflux	(VUR)	was	observed	in	127	PUV	patients	(64%).		Bilateral	
VUR was present in 73 (37%) and unilateral VUR in 54 (27%). At presentation, 
refluxing	patients	had	significantly	higher	serum	creatinine	values	than	patients	
without VUR. This was a distinctive feature in bilateral VUR and persisted at the 
6-	and	12-month	follow-up	visits.		Reflux	resolved	spontaneously	at	a	median	
of 1.28 years (range 0.04 to 15.16) after the release of the valvular obstruction. 
Of all patients, 44 (22.8%) had progression to ESRD at the evaluation, which 
occurred at a median age of 31 years (range 6 to 69); 30 (68%) had developed renal 
failure as a child, before the age of 17 years, and 14 (32%) as adults. In this study, 
the highest age at the onset of ESRD was 34 years. According to Kaplan-Meier 
analysis, the life-time risk of ESRD was 28.5% (SE 3.8%). Patients with higher 
creatinine	values	during	the	first	postoperative	year	had	progression	to	ESRD	at	
an	earlier	age.	Early	age,	poor	renal	function,	pneumothorax	and	bilateral	VUR	
at presentation and postoperative recurrent urinary tract infections (UTIs) were 
risk factors for ESRD.
Conclusions. The incidence of cryptorchidism is 16-fold higher and the incidence 
of inguinal hernia 7-fold higher in PUV patients than in the normal population. 
Cryptorchidism and inguinal hernias are more common in patients with more 
severe PUV. The underlying pathophysiological mechanisms remain unclear. 
The incidence of urinomas in PUV patients is currently 15%.  Renal function 
is similar in PUV patients with and without urinoma. The abolition of valves is 
probably	a	sufficient	operative	procedure	in	most	asymptomatic	cases.		
High voiding pressures were seen in infants around the ablation of the valves. 
No correlation between high voiding pressures and poor primary kidney function 
was observed. The voiding pressures were registered to decrease during the 
months following the release of the valvular obstruction. 
The incidence of VUR at the time of presentation was high, 64%. Bilateral VUR 
was	often	accompanied	by	reduced	overall	kidney	function.	Kidneys	with	refluxing	
units had worse primary function than contralateral kidneys. Spontaneous 
resolution of VUR occurred in half of the ureters within 2 years of abolition of 
valves,	more	rapidly	in	unilateral	than	in	bilateral	cases.	Antireflux	surgery	is	
most often not indicated. 
Posterior urethral valves often lead to ESRD. After patients reached the mid-
thirties, the risk subsided in this study. Early presentation, poor primary renal 
function,	pneumothorax	perinatally	as	well	as	VUR	bilaterally	and	recurrent	
postoperative UTIs carry a risk for renal function deterioration and ESRD. These 
risk factors should be recognized and proper management initiated, with follow-
up	extending	through	childhood	to	adulthood.
8LIST OF ORIGINAL PUBLICATIONS
LIST OF ORIGINAL PUBLICATIONS
This	thesis	is	based	on	the	following	original	publications,	referred	to	in	the	text	
by their Roman numerals:
I   Heikkilä J, Taskinen S, Toppari J, Rintala R: Posterior urethral valves are 
often associated with cryptorchidism and inguinal hernias. J Urol 2008; 180: 
715–717 
II  Heikkilä J, Taskinen S, Rintala R: Urinomas associated with posterior urethral 
valves. J Urol 2008; 180: 1476–1478 
III Taskinen S, Heikkilä J, Rintala R: Posterior urethral valves: primary voiding 
pressures and kidney function in infants. J Urol 2009; 182: 699-703 
IV		Heikkilä	J,	Rintala	R,	Taskinen	S:	Vesicoureteral	reflux	in	conjunction	with	
posterior urethral valves. J Urol 2009; 182: 1555-1560
V   Heikkilä J, Holmberg C, Kyllönen L, Rintala R, Taskinen S: Long-term risk 
of end stage renal disease in patients with posterior urethral valves. J Urol 
2011; 186: 2392-2396 
These publications have been reprinted with permission of their copyright holders. 
In addition, some unpublished material is presented.
9ABBREVIATIONS
BNI bladder neck incision
CBC cystometric bladder capacity
CI					 confidence	interval
CIC clean intermittent catheterization
CMD corticomedullary differentiation
CrEDTA chromium ethylenediamine tetra-acetic acid
DMSA dimercaptosuccinic acid
DTPA diethylenetriamine penta-acetic acid
ESRD end-stage renal disease
GFR	 glomerular	filtration	rate
ICCS International Children’s Continence Society 
IVU intravenous urography
LUT lower urinary tract
LUTD lower urinary tract dysfunction
LUTO lower urinary tract obstruction
MAG3 mercaptoacetyltriglycine
Pmax	det	 maximal	detrusor	pressure	
PUV posterior urethral valve(s)
SE standard error
UDT undescended testis
US ultrasonography
UTI urinary tract infection
UTO urinary tract obstruction
UUT upper urinary tract
VCUG voiding cystourethrography         
VUR	 vesicoureteral	reflux
VURD	 syndrome	of	posterior	urethral	valves,	unilateral	reflux	and	 
 renal dysplasia
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INTRODUCTION
Posterior urethral valves (PUV) constitute a rather rare congenital disorder with 
membranous obstruction of the male posterior urethra. This form of infravesical 
obstruction	is	potentially	seriously	detrimental	to	the	more	proximal	urinary	
system already prenatally.  Consequences to bladder and kidneys may be 
irreversible,	leading	to	chronic	renal	failure,	end-stage	renal	disease	and	finally	
to death. Given its rarity, most medical professionals do not encounter many 
PUV	patients,	and	few	units	have	more	than	a	limited	experience	in	treating	
them.  Nevertheless, in recent years mortality in PUV has been reported to have 
declined due to earlier diagnosis and referral to paediatric urological centers, 
improved instrumentation, achievements in pre- and postoperative management 
and	greater	experience	in	care	of	these	severely	ill	patients	(Cuckow	2006).	As	a	
consequence, there are now many patients requiring renal replacement therapy 
at a much earlier age (Dinneen and Duffy 1996, Cuckow 2006). Again paediatric 
surgeons and urologists treating these patients as a child rarely meet them in 
adulthood. Long-term outcomes of PUV are not properly known.  In Finland, 
late outcomes of PUV patients have not been investigated. Systematic follow-up 
studies elsewhere are also lacking.
The	aim	of	this	study	was	to	define	the	outcomes	of	PUV	patients	treated	
at Children’s Hospital, University of Helsinki, between 1953 and 2003, with a 
special emphasis on progression to ESRD and on risk factors for poor kidney 
outcome. In addition, the incidence of VUR and its association with primary kidney 
function and its spontaneous resolution are investigated. Moreover, the incidence 
of cryptorchidism and inguinal hernias and urinomas in PUV and the association 
with	primary	kidney	function	are	explored.	The	associations	of	primary	kidney	
function and voiding pressure and bladder capacity in infant patients are also 
evaluated.  
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HISTORY
Morgagni	first	described	the	autopsy	findings	of	PUV	in	1717	(Nesbit	and	Labardini	
1966, Dewan 1997, Krishnan et al. 2006, Hodges et al. 2009). The valves were 
mentioned again by Langenbeck in 1802 and Velpeau in 1826 (Young et al. 1919, 
Rattner et al. 1963, Dewan 1997, Nasir et al. 2011).
The clinical importance of PUV was presumably not understood until Budd 
presented a case report in Lancet in 1840 (Budd 1840).  A 16-year-old sailor was 
brought unconscious to hospital, dying there a few days later of uraemia and 
bilateral grave hydronephrosis. A membranous fold or valve of the posterior 
urethra and secondary changes in the bladder and UUT were described. Thirty 
years	later,	in	1870,	Tolmatschew	published	autopsy	findings	of	a	newborn	boy	
dying of renal failure. He also reviewed the previous literature (Tolmatschew 
1870). He found two thin membranes attached to the anterior part of the 
verumontanum and urethral wall, one to the right and the other to the left, in a 
semicircular manner. Flow and pressure from the direction of the bladder caused 
swelling of the membranes, and obstruction of the lumen preventing the bladder 
from	emptying.	This	author	was	also	the	first	to	discuss	an	embryological	basis	
for the disorder.
In 1913, Young published a case report of successful management of PUV 
(Young	et	al.	1919).			A	20-month-old	boy	had	severe	difficulties	in	passing	urine,	his	
bladder	was	distended	and	in	cystography	the	proximal	urethra	was	broad	and	an	
obstruction was present in the anterior part of the prostatic urethra. Suprapubical 
exploration	was	done	and	a	vertical	valve-like	obstructive	structure	was	felt,	which	
was destroyed by diathermy. The boy’s general health had improved rapidly and 
voiding	occurred	without	difficulty	for	one	year.	Unfortunately,	the	boy	then	died	
of diphtheria.  In 1919, Young published his classical work in which, on the basis 
of	his	own	and	previous	reports,	he	described	36	patients	and	classified	valves	
into three different types (Young et al. 1919). In 1937, Campbell according to 
Hendren reported 63 cases and gradually thereafter more and larger materials 
were	presented	and	finally	it	became	apparent	that	urethral	valves	were	not	rare,	
but far more common than earlier suggested (Hendren 1971).  
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CLASSIFICATION
According	to	Young’s	classification,	there	are	three	types	of	valves	(Young	et	
al. 1919).  Type I is described as folds located distally from the verumontanum 
and	fused	anteriorly.	Type	II	represents	folds	that	run	proximally	between	the	
verumontanum and bladder neck. Type III is illustrated as a diaphragm with 
an	opening	distal	to	the	verumontanum	(Young	et	al.	1919).		This	classification	
has, however, been questioned. Apparently type II is not obstructive and is 
generally	considered	to	be	hypertrophied	superficial	muscle	and	mucosa	between	
the verumontanum and bladder neck. Differences between type I and III have 
also been re-evaluated.  These have been argued to represent originally the 
same diaphragmatic type, which has converted to separate folds after urethral 
manipulation while inserting a catheter or an instrument (Robertson and Hayes 
1969, Dewan 1993, Dinneen and Duffy 1996, Kajbafzadeh 2005, Cuckow 2006, 
Krishnan	et	al.	2006).	Presman	in	his	post-mortem	study	described	five	of	his	
seven patents to have an iris or diaphragm-type obstruction (Presman 1961). 
Robertson and Hayes in autopsy of 20 deceased infants with congenital urethral 
obstruction removed the entire urinary tract including the penis en block. After 
detailed anatomical dissection in which special care was taken in removing the 
anterior wall of the prostatic urethra, bladder neck and bladder, they consistently 
found	an	oblique	diaphragm	with	fibrous	connective	tissue	membrane	on	each	side	
with transitional epithelium and considered it to be responsible for the obstruction 
(Robertson and Hayes 1969).  In accordance with this, Parkkulainen (1977) by 
endoscopic photographs documented all of his patients with a diaphragmatic 
type of obstruction initially. The term congenital obstructing posterior urethral 
membrane (COPUM), originally suggested by Dewan (1993), has been taken into 
use and deemed appropriate by some authors (Kajbafzadeh 2005, Krishnan et al. 
2006, Hodges et al. 2009, Lazarus 2011). It has not, however, gained universal 
acceptance	in	clinical	practice.	Nevertheless,	classification	has	been	suggested	
to have no true value in clinical judgement with respect to management and 
prognosis of urethral obstruction (Kajbafzadeh 2005, Cuckow 2006). 
EMBRYOLOGY 
The cloaca divides into an anterior primitive urogenital sinus and a posterior 
rectum around 28 days after fertilization (Cuckow et al. 2001).  The upper part of 
the primitive urogenital sinus forms the vesicourethral canal, which is the point 
of	origin	of	the	final	bladder	and	proximal	urethra.	The	distal	part	of	primitive	
urogenital	sinus	will	form	the	definitive	urogenital	sinus.	In	males,	it	gives	rise	
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to	the	posterior	urethra.	The	paired	Wolffian	ducts	open	at	about	six	weeks	to	
Müller’s tubercle, which will form the verumontanum in males. The bulbar urethra 
and the pendulous urethra are derived from the urethral plate on the ventral aspect 
of the genital tubercle (Cuckow et al. 2001, Krishnan et al. 2006).
The embryology of PUV is not known. Many theories have been presented. 
Currently, four major hypotheses prevail (Rattner et al. 1963, Friedland et al. 
1977, Agarwal 1999, Kajbafzadeh 2005, Krishnan et al. 2006, Casella et al. 2012). 
Tolmatschew	proposed	that	the	valves	were	an	overgrowth	of	normally	existing	
folds and ridges (Tolmatschew 1870). Bazy in 1903 suggested that the remnants 
of the urogenital membrane were responsible for the valves (Friedland et al. 1977, 
Agarwal 1999, Krishnan et al. 2006). Lowsey in 1914 concluded that PUV were due 
to	an	anomaly	of	the	Wolffian	and	Müllerian	duct	junction	(Friedland	et	al.	1977,	
Agarwal 1999, Krishnan et al. 2006). According to Watson in 1922, persistence 
of the attachment of the verumontanum to the roof of the urethra and arrested 
fusion of the mucosal lining were responsible for PUV (Friedland et al. 1977, 
Agarwal 1999, Krishnan et al. 2006).  Stephens suggested separate mechanisms 
for valves I and III. He supported the theory of Lowsey in type I and Bazy in type 
III obstruction (Krishnan et al. 2006).  At present, the embryological mechanisms 
of PUV remain uncertain (Agarwal 1999, Kajbafzadeh 2005).
AETIOLOGY 
The aetiology of posterior urethral valves is unknown. PUV is most commonly 
sporadic. However, familial cases have been reported in two successive generations, 
in siblings and in identical and fraternal twins (Schreuder et al. 2008, Morini et 
al.	2002,	Weber	et	al.	2005).	These	findings	may	suggest	some	form	of	genetic	
background. Also recent analyses of congenital anomalies of the kidney and 
urinary tract (CAKUT) have proposed a common genetic mechanism (Pope et al. 
1999, Weber et al. 2005, Song and Yosypiv 2011). However, the understanding 
of the molecular biology of human kidney and urinary tract organogenesis has 
thus	far	been	insufficient (Song and Yosypiv 2011).  
INCIDENCE
The incidence of PUV is estimated in general to be between 1/3000 and 1/8000 
(Yohannes	and	Hanna	2002,	Hodges	et	al.	2009),	but	figures	indicating	a	rarer	
presentation, e.g. 1/25 000, have also been reported (Atwell 1983). In Oman, a 
general incidence of 1/2375 in newborn males has been observed (Rajab et al. 
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1996). In different districts of Oman, the incidences have ranged between 1/1700 
and 1/5500.  Interestingly, in a prospective prenatal US analysis 1/1285 infants 
was detected to have PUV (Gunn et al. 1995).  Consequently, the true incidence 
of	PUV	at	present	is	unknown,	but	the	figure	may	be	even	higher	than	commonly	
assumed. 
ASSOCIATED ANOMALIES 
Posterior urethral valves are predominantly regarded as an isolated malformation. 
However, numerous congenital disorders in other organ systems have been 
reported in conjunction with PUV. These include single organ abnormalities and 
syndromes, virtually all of which are case reports.  Rajab et al. (1996) managed to 
document in a detailed study of 84 PUV patients several urological, gastrointestinal 
and	spinal	anomalies,	i.e.	cryptorchidism,	hypospadias,	meatal	stenosis,	duplex	
kidney, ureteropelvic junction obstruction, dysplastic kidney, solitary kidney, 
ureteric diverticulum, inguinal hernia, anal stenosis, high anorectal anomaly, 
Hirschsprung disease,	spina	bifida,	hemivertebra,	scoliosis,	congenital	heart	
disease and mental retardation. Additional reported anomalies are anterior 
urethral valve (Rao et al. 2003, Bhagat et al. 2008), megalourethra (Krueger 
and Churchill 1981), double urethra (Hendren 1971, Saigal et al. 2003), crossed 
renal ectopia (Hendren 1971), duplication of colon (Friedland et al. 1977) and 
imperforate anus (Hendren 1971, Shiraishi and Takihara 2004, Banever and 
Moriarty 2005).  Syndromes include prune belly (Hendren 1971, Barker et al. 
1993), Bardet-Biedl (Valavi et al. 2009), Beckwith-Wiedemann (Buyukcelik et 
al. 2005), Gorlin-Cohen (Vakalopoulos et al. 2012), de Goldenhaar (Palacios et 
al. 2007), Klinefelter (Nwosu and Hopkins 2008), Noonan (Barker et al. 1993), 
Ochoa (Weber et al. 2005) and Townes-Brocks (Weber et al. 2005). 
The relationship between PUV and Down syndrome has been studied somewhat 
more closely. This chromosome aberration has been reported frequently among 
valve patients (Kupferman et al. 1996, 2009, Bielek et al. 1996, Hausmann and 
Landau 2002, Narasimhan and Gupta 2004, Culty et al. 2006, Ebert et al. 2008) 
and has been observed in 4-7% of patients with PUV (Kupferman et al. 1996, 2009 
Bielek et al. 1996). Consistently, the risk of PUV in Down syndrome has been 
noted to be about 7-fold relative to those without the syndrome (Kupferman et 
al. 2009).		No	determinate	explanation	for	the	link	between	these	two	disorders	
has yet emerged. 
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CRYPTORCHIDISM 
Cryptorchidism is usually reported to be found in 2-4% of full-term male infants 
(Hughes and Acerini 2008, Hutson et al. 2010).  In a previous study comparing 
cryptorchidism in two Nordic countries, the prevalence at birth was 9.0% in 
Denmark and 2.4% in Finland (Boisen et al. 2004). The testis commonly descends 
at	birth,	but	some	spontaneous	migration	may	still	occur	during	the	first	months	
of postnatal life. At the age of one year, the incidence of undescended testes 
requiring surgery is on average 0.8-1% (Frey and Rajfer 1982, Hutson and Beasley 
1992). In the aforementioned prospective two-centre study, the prevalence at 
three months was 1.9% in Denmark and 1.0% in Finland, and at 18 months the 
corresponding	figures	were	1.5%	and	1.0%	(Boisen	et	al.	2004).	Descent	of	the	
testis is a complicated process with several factors participating. According to 
current evidence, normal testicular descent is believed to take place in two distinct 
phases, each having separate mechanisms (Mickel 1982, Hutson and Hasthorpe 
2005, Virtanen et al. 2007, Hughes and Acerini 2008, Hutson et al. 2010). The 
transabdominal phase occurs at 8-15 weeks of foetal life and the inguinoscrotal 
phase at 25-35 weeks (Hutson and Hasthorpe 2005, Hughes and Acerini 2008, 
Hutson	et	al.	2010).	The	gubernaculum	fixes	to	the	cauda	epididymis	and	anchors	
the testis to the inguinal region of the abdominal wall, and also participates 
in the canalicular and scrotal transition. Intra-abdominal pressure is believed 
to be important for normal descent (Backhouse 1982, Mickel 1982, Taskinen 
1997, Hutson et al. 2010). Mechanical conditions and hormonal interactions are 
involved throughout the process. Insulin-like hormone 3, Leydig cell product, and 
anti-Müllerian hormone, Sertoli cell product have been suggested to be involved 
in the transabdominal phase (Hutson and Hasthorpe 2005, Hughes and Acerini 
2008, Hutson et al. 2010). Androgens are required in the inguinoscrotal phase, 
and increased abdominal pressure presumably promotes the passage of the testis 
and epididymis through the canal (Backhouse 1982, Taskinen 1997, Hughes and 
Acerini 2008, Hutson et al. 2010). Genitofemoral nerve and its neurotransmitter 
may take part in this stage (Larkins et al. 1991, Hughes and Acerini 2008, Hutson 
et al. 2010). Lack of descent may be caused by hormonal defects or mechanical 
conditions. Prune belly syndrome and abdominal wall defects, bladder and 
cloacal	extrophy,	omphalocele	and	gastroschisis	have	increased	frequency	of	
cryptorchidism, possibly secondary to bladder enlargement interfering with 
inguinal ring or changes in intra-abdominal pressure (Kaplan et al. 1986, Merksz 
and Toth 1990, Hutson and Beasley 1992, Koivusalo et al. 1998). Children with 
neural tube defects may have dysfunction of the genitofemoral nerve as a cause 
for retained testis (Hutson and Beasley 1992, Hutson et al. 2010). In patients with 
PUV, an incidence of cryptorchidism of up to 12% has been reported (Krueger et 
al.	1980b,	Barker	et	al.	1993).	The	exact	relationship	between	undescended	testes	
and PUV and potential mechanisms have not been well established.
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PATHOANATOMY 
The valves of the posterior urethra cause anatomical obstruction of the urethral 
tube. The severity of the obstruction varies from one patient to another. The 
narrower	the	luminal	hole	in	PUV,	the	greater	the	resistance	to	urine	flow,	probably	
resulting	in	secondary	deleterious	effects	to	the	entire	proximal	urinary	tract.	
Renal growth and function impairment in proportion to the severity and duration 
of obstruction have been noted in animal models (Chevalier 2008, Chevalier 
et	al.	2010).	There	are,	of	course,	many	other	mechanisms	that	exacerbate	the	
renal	damage.	Typical	findings	of	the	urinary	tract	are	dilatation	and	elongation	
of	prostatic	urethra,	while	the	bladder	neck	remains	rather	narrow.		Reflux	to	
seminal vesicles, vasa deferentia and epididymis as well as to ureters may also take 
place. The bladder wall becomes trabeculated and thickens, and diverticulas may 
develop. Changes in the bladder wall constitute muscular hypertrophy, alterations 
in quality and amount of collagen, myosin and elastin resulting in a thick-walled 
non-compliant bladder (Rink and Mitchell 1990, Kim et al. 1991, Peters et al. 
1992). Consequently, the bladder loses contractile strength and compliance and 
may	develop	high	filling	pressures.	These	changes	may	be	irrecoverable	and	are	
responsible for the bladder dysfunction. Hypertrophy of detrusor muscle and 
elevated intravesical pressure disturbs ureterovesical junction anatomy and 
function. Higher pressure communicates back towards the kidney, inducing 
destruction of renal parenchyma, but also leading to malformation and reduction 
of the developing nephrons in utero (Peters 1997, Chevalier and Forbes 2008, 
Chevalier et al. 2010). Impaired nephrogenesis and nephron maturation in utero 
and in the infantile kidney are possible. 
Response of the foetal kidney to obstruction appears to be distinct from 
that of the postnatal kidney (Peters 1997).  Not only can foetal urinary tract 
obstruction (UTO) impact eventual renal function, but it appears to alter the 
very foundation of renal function by changing renal growth and differentiation 
(Peters 1997).  In animal models, ureteral and urethral obstruction has been 
shown to produce hydronephrosis, renal cystic and dysplastic changes and 
impaired renal growth (Peters 1997, Chevalier et al. 2010). Tubular dilatation 
and apoptosis, glomerulotubular disconnection, reduction of the number 
of nephrons and interstitial fibrosis have been noted also in children with 
obstructive nephropathy (Chevalier et al. 2010). There is increasing evidence 
that in obstructive nephropathy destruction of the nephron begins in the renal 
tubule (Chevalier and Forbes 2008). In contrast, the proponents of bud theory 
tend	to	think	that	dysplastic	alterations	are	defined	as	primary	developmental	
malformations	and	are	explained	by	inaccurate	location	of	the	ureteral	bud	and	
interaction with the renal blastema (Henneberry and Stephens 1980, Pope et al. 
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1999, Haecker et al. 2002). Accordingly, ectopic origins of ureteral buds lead to 
induction of defective or sparse mesenchyme of the tail end of the nephrogenic 
cord, with the result of dyplasia and hypoplasia. An abnormally lateral ureteral 
orifice	in	the	bladder	further	predisposes	to	vesicoureteral	reflux.	In	any	case,	renal	
dysplasia and hypoplasia in association with PUV are well-known major structural 
abnormalities.  Polyuria is associated with nephrogenic diabetes insipidus caused 
by injury to the renal collecting tubules (Dinneen et al. 1995, Naghizadeh et al. 
2005).  Equally sustained polyuria and bladder overdistention are capable of 
leading to increased infravesical pressure and upper tract dilatation and renal 
injury (Koff et al. 2002). In addition, PUV patients may develop reflux nephropathy 
in the presence of VUR.  Pyelonephritis,	hyperinfiltration	and	glomerulosclerosis	
alone or with the other mechanisms may further damage the kidneys (Dinneen 
and Duffy 1996, Cuckow 2006).  
DIAGNOSIS
CLINICAL FEATURES
After birth, boys with the worst obstruction generally present early (Pieretti 1993, 
Imaji and Dewan 2001).  Severe oligohydramnios or anhydramnios predisposes 
to life-threatening pulmonary hypoplasia and respiratory distress and even to 
Potter sequence (Soo 2004, Cuckow 2006). Other prevailing symptoms and signs 
in neonates and infants are palpable urinary tracts, distended bladder, palpable 
kidneys, or urinoma, poor stream, dribbling, vomiting, failure to thrive, infectious 
complications, urinary tract infection and sepsis, and haematuria (Cuckow 2006). 
Voiding symptoms, incontinence, haematuria and UTI have been observed to 
be the most common symptoms in late presenting PUV (Bomalaski et al. 1999, 
Yohannes and Hanna 2002, Schober et al. 2004). Adults have been reported 
to predominantly have voiding and ejaculatory dysfunction (Marsden 1969, 
Dutkiewicz 1994, Nguyen and Peters 1999).
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Urinoma
Urinoma results from disruption of the urinary collecting system and escape of 
urine	at	any	level	from	the	calyx	to	the	urethra	(Titton	et	al.	2003).	Most	commonly,	
urine leaks result from blunt or penetrating trauma or increased back pressure 
caused by obstruction of the genitourinary system (Macpherson et al. 1986, Titton 
et	al.	2003,	Sancho	Calvache	and	Pomares	Amigó	2008).		Urinary	extravasation	
may initially be clinically occult and may manifest with delayed complications. The 
majority of neonate urinomas relate to lower urinary tract obstruction (LUTO), 
the commonest cause being PUV (Kay et al. 1980, Macpherson et al. 1986, Huang 
and Cheng 1990). The supposed mechanisms to the escape of urine in infravesical 
obstruction are rupture of thinned renal parenchyma, leak from calcyleal fornices, 
bladder	rupture	and	transudation	of	urine	(Greenfield	et	al.	1982,	Patil	et	al.	
2003). Perirenal urinoma and urinary ascites are the most often reported sequelae. 
Urinothorax	is	believed	to	result	from	retroperitoneal	or	transdiaphragmatic	shift	
of retroperitoneal or intraperitoneal collection into the pleural space (Garcia-
Pachon and Padilla-Navas 2004, Lee et al. 2005, Sancho Calvache and Pomares 
Amigó 2008). Urinomas have been reported to occur in 1-8.5% of PUV patients 
(Greenfield	et	al.	1982,	Rittenberg	et	al.	1988,	Patil	et	al.	2003).	Because of the 
small	patient	numbers	in	individual	reports,	the	significance	of	urinoma	in	this	
disorder is in many ways unclear. The clinical characteristics of PUV patients with 
or without urinoma have not earlier been thoroughly compared. 
ANTENATAL DIAGNOSIS
In congenital obstructive disease, the nature and location of the obstruction 
and its impact on the upper urinary tract must be determined. During the last 
decades US has become an essential tool in maternal care and foetal evaluation. 
The male foetus showing bilateral hydronephrosis with a constantly distended 
and thick-walled bladder is known to be suggestive for LUTO, and thus, for PUV 
(Agarwal 1999). A dilated prostatic urethra can occasionally be seen and a “keyhole 
sign”,	representing	an	enlarged	bladder	and	dilated	proximal	urethra,	adds	to	
the reliability of a diagnosis of urethral obstruction (Vanderheyden et al. 2003, 
Quintero	2005).	However,	a	definite	diagnosis	of	the	underlying	aetiology	causing	
LUTO is deemed impossible using prenatal US alone (Thomas 2001, Lissauer et 
al. 2007, Ruano 2011).
The fast scanning technique of magnetic resonance imaging offers a valuable 
aid to US of the foetal urinary tract if resolution is impaired because of severe 
oligohydramnion or for other reasons (Poutamo et al. 2000, Payabvash et al. 
2008, Ruano 2011). 
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IMAGING
Ultrasound is, in most cases, the primary imaging method. It detects kidney size 
and	confirms	hydronephrosis	and	may	suggest	the	cause	and	even	the	anatomical	
site of the obstruction. US can also differentiate parenchymal changes according 
to alterations in echogenicity, is easily available and allows repeated investigations 
without radiation.
Voiding cystourethrography (VCUG) locates and demonstrates the 
obstruction	exactly	and	is	the	most	valuable	radiological	examination.	It	is	
the diagnostic method of choice to image the bladder and urethra. VCUG also 
identifies	preobstructive	secondary	changes	in	the	urinary	tract	and	registers 
vesicoureteral	reflux.	Moreover,	it	detects	and	grades	VUR	(Ismaili	et	al.	2006,	
Mathews et al. 2009). 
 
Figure 1. Ultrasound: Hydroureteronephrosis in a 5-year-old boy with UTI.  Hydronephrosis 
(upper arrow) and wide ureter (lower arrow).
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Figure 2. Ultrasound: Thick trabeculated bladder wall (upper arrow) and megaureters  
(lower arrows) suggestive of PUV in a 5-year-old boy with UTI.  
Figure 3. Voiding cystourethrography: Trabeculated bladder (triangle), high-grade 
vesicoureteral reflux (upper star), prominent bladder neck (upper arrow), dilated posterior 
urethra (lower star) and PUV (lower arrow).
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Radionuclide cystography (RNC) reliably detects VUR, but does not allow 
morphological changes in the urinary tract to be evaluated. RNC is usually reserved 
for follow-up studies of VUR (Cooper 2009).  
Mercaptoacetyltriglycine (MAG3), diethylenetriamine penta-acetic acid 
(DTPA) and dimercaptosuccinic acid (DMSA) scintigraphy are sensitive to renal 
dysplasia and scarring, and also allow evaluation of relative renal function. MAG3 
and	DTPA	have	additional	value	in	judging	co-existing	obstructive	states	of	UUT.
Intravenous urography (IVU) has historically been the major imaging technique 
and is capable of demonstrating the anatomy of UUT in the presence of reasonable 
renal function. Currently, it has been replaced by modern scintigraphy and US 
(Gordon et al. 1987, Chevalier 2008).  
Magnetic resonance voiding cystography (MRVC) and magnetic resonance 
urography (MRU) are not at present widely available. They are, however, safe 
methods with no ionizing radiation and are potential alternatives as primary 
imaging modalities in evaluation of UTO (Leppert et al. 2002, Perez-Brayfield	et	
al. 2003, Lee et al. 2005, Chevalier 2008). 
URETHROCYSTOSCOPY
Urethrocystoscopy	enables	identification	of	the	valves.	Urethroscopy	allows	the	
valves to be visualized directly. Bladder wall trabeculation and diverticula and 
the	localization	and	shape	of	ureteric	orifices	can	also	be	viewed	and	evaluated	
endoscopically. 
URODYNAMIC EVALUATION OF BLADDER DYSFUNCTION 
Lower urinary tract dysfunction (LUTD) is frequent in boys with PUV. Of those 
referred to urodynamic evaluation, over 70% have been reported to have severe 
dysfunction (Bauer et al. 1979, Parkhouse and Woodhouse 1990, Peters et al. 1990, 
Holmdahl et al. 1995, De Gennaro et al. 2000). In addition, a non-compliant thick-
walled bladder, incontinence and nephrogenic diabetes insipidus with persistent 
UUT dilatation following valve ablation have been described and collectively 
are referred to as ‘valve bladder syndrome’ (Glassberg 2001, Koff et al. 2002, 
Taskinen et al. 2012). However, Koff et al. (2002) noted small, hypercontractile, 
poorly compliant bladders to not only reach normal capacity with age but become 
overdistended. According to Koff et al., valve bladder syndrome results from 
sustained bladder overdistention that is caused by a combination of polyuria, 
impaired bladder sensation and high residual urine volume (Koff et al. 2002). 
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In 2006, the International Children’s Continence Society (ICCS) updated the 
standardized terminology of LUT function in children (Nevéus et al. 2006). 
According	to	the	modified	ICCS	terminology,	the	three	most	commonly	found	
urodynamic patterns in patients with PUV are as follows: 1. detrusor overactivity, 
2. low bladder compliance and 3. myogenic failure (detrusor underactivity) (Peters 
et al. 1990, Holmdahl et al. 1995, De Gennaro et al. 2000, Lopez Pereira et al. 
2002,	Kajbafzadeh	et	al.	2007).	The	incidence	of	these	findings	has	been	observed	
to vary and overlap between the groups, presumably related to the age of the 
patient. In PUV patients, detrusor overactivity, which is frequent in infancy, has 
a tendency to become underactive with age. Accordingly, hypocontractibility 
and myogenic failure have been reported in older children. Successive increase 
in bladder capacity is suspected to be accompanied by a risk for overdistention 
(Holmdahl et al. 1997, De Gennaro et al. 2000, Kajbafzadeh et al. 2007). This 
concept of changing urodynamic patterns is not, however, universally accepted. 
In infants, at the time of diagnosis of PUV, bladder function has rarely been 
evaluated, and the association between voiding pressures and kidney function is 
unclear.
MANAGEMENT
ANTENATAL MANAGEMENT
Foetal	surgery	for	treatment	of	obstructive	uropathy	was	first	reported	in	humans	
at the University of California, San Francisco, in 1981 (Holmes et al. 2001). In 
this series, such procedures as placement of vesicoamniotic shunt, bladder 
marsupialization, ablation of valves and cutaneous ureterostomies were utilized 
(Holmes et al. 2001).  Open foetal surgery has since been abandoned almost 
completely because of increased maternal and foetal risks. Alternative minimally 
invasive approaches have been developed instead, with the rationale of restoring 
the	amniotic	fluid,	thus	preventing	lung	hypoplasia,	and	decompressing	the	
urinary tract to protect against renal impairment (Lissauer et al. 2007, Ruano 
2011, Casella et al. 2012). The most common procedure to relieve LUTO is to place 
a stent, a percutaneous vesicoamniotic shunt. Another option is foetal endoscopy 
and treatment of valves. It has been postulated that this latter procedure allows 
restoration of normal foetal bladder dynamics (Quintero et al. 2000, Lissauer et 
al. 2007). However, thus far,	human	studies	have	failed	to	show	any	benefit	of	
antenatal intervention for preserving normal renal function (Morris et al. 2010, 
Casella et al. 2012). The overall perinatal survival rate after shunt placement was 
only	47%	and	shunt-related	complications	were	45%	in	a	report	summarizing	five	
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larger series comprising 169 patients in total (Agarwal and Fisk 2001). Also in 
foetal cystoscopy an average of 50% survival has been reported in a collected series 
(Ruano 2011). Antenatal management has not attained wide acceptance to date. 
Since	the	amniotic	fluid	level	is	maintained	by	foetal	urine	production	after	around	
the 16th week of gestation, irreparable damage may have occurred in the foetus 
before critical obstruction is noted (Holmes et al. 2001). Antenatal management 
is	considered	experimental	and	is	hampered	by	severe	complications,	including	
preterm labour and foetal death. It has been proposed, however, that the future 
of valve therapy may well lie in foetal surgery, as the equipment and techniques 
used to treat foetal urinary tract obstruction evolve (Hodges et al. 2009).
POSTNATAL MANAGEMENT
Laboratory	examinations	include	assessment	of	renal	function	and	UTI.	Microscopic	
examination	and	culture	of	urine	are	routine.	Renal	function	is	estimated	by	
measuring	serum	creatinine,	and	later	glomerular	filtration	rate	(GFR)	is	determined	
more accurately by creatinine clearance or chromium ethylenediamine tetra-acetic 
acid (CrEDTA) values (Ylinen 2004, Kajbafzadeh 2005). 
Bladder drainage is established by either urethral or suprapubic catheter. 
Simultaneous correction of electrolyte and acid-base imbalance and control over 
infection are crucial. Electrolyte and acid-base balance are monitored frequently. 
Hyperkalemic acidosis is a known common serious sequela (Dinneen and Duffy 
1996, Kajbafzadeh 2005).
Valve ablation
Ablation of valves as a surgical treatment is the preferred option as soon as the 
child’s overall condition has stabilized. Most paediatric urologists agree that 
endoscopic valve resection is the preferred method for removing posterior urethral 
valves (Hulbert and Duckett 1988, Lopez Pereira et al. 2004, Sarhan et al. 2010, 
Smeulders et al. 2011). 
The	endoscopic	approach	allows	identification	and	destruction	of	the	valves	
under direct vision. This can be performed in a retrograde or antegrade fashion, 
the former being more typical (Hulbert and Duckett 1988, Yohannes and Hanna 
2002, Cuckow 2006). The narrowest point of a child’s urethra is the meatus. This 
may be gently dilated to allow an appropriate-sized cystoscope to be introduced. 
However, it is important not to over-dilate the urethra by using a larger cystoscope 
than the urethra can accept (Agarwal 1999). The valves can be abolished by the 
preferred instrumentation available, e.g. resectoscope loop, cutting or electrode 
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knife,	hook,	laser	or	inflated	balloon	catheter	(Yohannes	and	Hanna	2002,	Cuckow	
2006, Nasir et al. 2011). 
Bladder	neck	incision	(BNI)	is	considered	to	be	seldom	justified,	and	most	
authors advocate avoiding BNI to minimize bladder neck contracture and 
incontinence (Yohannes and Hanna 2002). However, some recent reports 
have stated that a degree of bladder neck hypertrophy may accompany valvular 
obstruction (Androulakakis et al. 2005, Kajbafzadeh et al. 2007). Accordingly, BNI 
in conjunction with valve resection has again been suggested to improve bladder 
dynamics (Androulakakis et al. 2005, Kajbafzadeh et al. 2007, Lazarus 2011). 
Also BNI has been recommended in late presenting adult patients with persistent 
severe bladder neck contracture after resection of PUV (Culty et al. 2006).
Urinary diversion
Urinary diversion has had priority in management of infants with a urethra that 
is too small to allow passage of instruments or in the critically ill with resistant 
urinary infection and insufficient drainage of the UUT with rising plasma 
creatinine values after ablation of valves (Agarwal 1999, Nasir et al. 2011). Krueger 
and associates have shown that those neonates and infants with primarily upper 
tract diversion compared with primary valve resection had better growth and 
better renal function at an average follow-up of 7.4 years (Krueger et al. 1980a, 
Churchill et al. 1983). By contrast, temporary or permanent reduction of bladder 
volume was seen in 15 patients with defunctionalized bladder secondary to 
cutaneous ureterostomy diversion in the report of Lome et al. (1972).  Probably 
these	latter	findings	and	the	development	of	infant	instruments	and	neonatal	
intensive care lead to preference of straightforward endoscopic ablation without 
diversion. Smith et al. (1996) in a series of 100 patients concluded that PUV should 
be treated with primary valve ablation and vesicostomy should be reserved for 
those in whom ablation is technically impossible. They judged high diversion as 
disadvantageous.  Much of the criticism against supravesical urinary diversions 
was	based	on	modifications	where	the	bladder	was	defunctionalized	(Liard	et	
al. 2000). However, alternative techniques, such as Sober pelviureterostomy, 
ureteral chimney and ring ureterostomy, allow bladder cycling. Recently Lopez 
Pereira and associates (2003) observed again that the patients treated with early 
temporary	pyelo-ureterostomy	had	a	better	renal	function	in	follow-up.	Benefits	
of	cutaneous	supravesical	diversion	were	obvious,	and	justification	for	temporary	
urinary diversion in order to improve renal function prognosis in some particular 
cases	was	affirmed	(Lopez	Pereira	et	al.	2003,	2004).
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Vesicoureteral reflux and auxiliary surgery 
Vesicoureteral	reflux,	retrograde	flow	of	urine	from	the	bladder	into	the	ureter,	is	
generally estimated to occur in 1-3% of children (Fanos and Cataldi 2004, Cooper 
2009).		However,	also	much	higher	figures	have	been	proposed	(Venhola	2011).	
The estimation of the severity of VUR is determined according to VCUG, which is 
regarded	as	the	gold	standard	for	imaging	reflux	(Ismaili	et	al.	2006,	Mathews	et	
al. 2009).  Clinicians have been advised to use the well-established grading system 
adopted	by	the	International	Reflux	Study	Committee	(IRSC),	which	is	based	on	
the	classification	originally	presented	by	Heikel	and	Parkkulainen	(1966)	(Tekgül	
et al. 2012).  Grade I visualizes the escape of contrast medium into the ureter 
only and grade II into an anatomically normal pyelocalyceal system.  Grade III 
constitutes	reflux	to	the	dilated	collecting	system,	and	in	grade	IV	there	is	more	
pronounced dilatation with blunting of the calyces and tortuosity of the ureter. 
Grade	V	represents	massive	reflux	with	gross	dilatation	and	deformation	of	the	
collective system and ureter (Heikel and Parkkulainen 1966, Tekgül et al. 2012).
Primary VUR is presumed to be related to the anomalously short intravesical 
tunnel at the ureterovesical junction or to LUTD (Cooper 2009, Tekgül et al. 2012). 
The demonstration of spontaneous resolution of primary VUR has led to the 
concept of initial conservative management and limitation of surgical correction 
to those patients who fail to recover with these non-operative regimens (Mathews 
et al. 2009, Tekgül et al. 2012). 
PUV are accompanied by VUR with reported incidences usually between 
26% and 72% (Dinneen and Duffy 1996). VUR in these patients is considered 
to be secondary to the increased infravesical pressure and loss of ureterovesical 
junction competence (Jaureguizar et al. 2002, Hassan et al. 2003, Lopez Pereira 
et al. 2004). Dilated UUT combined with persistent UTI has been reported to 
be associated with high morbidity and mortality in the past (Hendren 1971, 
Williams et al. 1973). Early ureterovesical reconstruction, reimplantation 
and remodelling of ureters have been proposed in cases with gross dilatation 
of the upper urinary tract (Hendren 1971, Bjordal et al. 1978, Casale 1990). 
Recently El-Sherbiny and associates reported 20% of their patients to have 
undergone ureteroneocystotomy.  However, 26% had postoperative VUR and 
4% ureterovesical junction obstruction as a complication to the procedure (El-
Sherbiny et al. 2002). Currently, the majority of paediatric urologists advocate 
observational regimens after release of the distal obstruction (Connor and 
Burbige 1990, Smith et al. 1996, Farhat et al. 2000). However, there are few 
studies concerning resolution of VUR after ablation of urethral valves. VUR 
has	been	reported	to	subside	spontaneously	in	27-79%	of	refluxing	ureters	in	a	
period of 2 weeks to more than one year after ablation of valves (Johnston and 
Kulatilake 1971, Johnston 1979, Scott 1985, Lal et al. 1998b, Farhat et al. 2000, 
Priti et al. 2004). True long-term studies concerning the resolution of VUR and 
26
REVIEW OF THE LITERATURE
renal	function	in	PUV	patients	are,	however,	scarce.		Reflux	has	been	noted	to	
be	associated	with	renal	failure,	especially	in	cases	of	bilateral	reflux	(Johnston	
1979, Tejani et al. 1986, Parkhouse et al. 1988, Denes et al. 1997, Oliveira et al. 
2002). On the other hand, opposing views have been presented, and unilateral 
reflux	with	the	ipsilateral	non-functioning	kidney	has	been	suggested	to	protect	
contralateral	kidney	function	(Hoover	and	Duckett	1982,	Greenfield	et	al.	1983,	
Donnelly et al. 1997, Oliveira et al. 2002). Nephrectomy has been adopted in 
recurrent or resistant UTI in patients with a non-functioning kidney.  Previously, 
17-19% of valve patients have undergone removal of a non-functioning kidney 
(Cuckow et al. 1997, Atwell 1983, Holmdahl and Sillén 2005). However, the 
significance	and	proper	management	of	VUR	in	boys	with	PUV	remain	in	many	
respects controversial. 
OUTCOMES
SURVIVAL
During the early years of management primary mortality was high. The mortality 
rates particularly among those presenting as neonates were rather miserable. 
Johnston and Kulatilake reported rates of 50%, Williams 52% and Retief and 
Shippel 75% in patients presented under the age of one month (Johnston and 
Kulatilake 1971, Williams et al. 1973, Retief and Shippel 1976).  The overall mortality 
in these series was 32%, 16% and 33%, respectively.  Egami and Smith (1981) 
reported 49% neonatal mortality and 21% overall mortality.  Cass and Stephens 
(1974) witnessed a dramatic decline in neonatal and overall mortality from 78% 
to 15% and 22% to 6%, respectively, from 1950-1961 to 1962-1972.  Consistently, 
Churchill and associates (1983) reported a profound reduction in overall mortality 
from 25% in 1957-1968 to 3% in 1969-1978.  In the work of Cass and Stephens, 
deaths occurred during initial hospitalization, and in the study of Churchill and 
associates,	with	one	exception,	within	12	months	of	diagnosis.			During	the	1980s	
mortality of 0% from the latter institution was reported (Churchill et al. 1990). 
Later,	mortality	figures	of	0-2%	at	many tertiary referral children’s hospitals have 
been published (Dinneen and Duffy 1996).
Improvement is concluded to be related to better awareness of the valves, 
earlier diagnosis and referral, advancements in neonatal intensive care, better 
antibiotics, more sophisticated surgical instruments and improvements in 
the management of neonates and infants with acute and chronic renal failure 
(Churchill et al. 1983, Cuckow 2006). 
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POSTOPERATIVE MORBIDITY AND COMPLICATIONS
The incidence of complications after valve ablation has typically ranged between 
5% and 28% (Yohannes and Hanna 2002, Kajbafzadeh 2005).
Urethral stricture after ablation of valves has occured in 8-28% of patients 
(Churchill	et	al.	1983).	Since	the	early	years	of	management,	these	figures	seem	
to have declined to 4-8% (Crooks 1982, Lal et al. 1998a, Sudarsanan et al. 2009). 
Currently, the prevalence of urethral stricture has been observed to be very low, 
2% (Sarhan et al. 2010) or even 0% (Bhatnagar et al. 2000, Chertin et al. 2002, 
Caione and Nappo 2011). 
Residual valves necessitating second ablation have been reported in 1-29% 
of patients (Kimbrough and Wyker 1977, Bhatnagar et al. 2000, Chertin et al. 
2002, Bani Hani et al. 2006, Sudarsanan et al. 2009, Sarhan et al. 2010, Babu 
and Kumar 2013).
Other reported complications include postoperative urinary retention, 
postoperative urethral bleeding, intraperitoneal leak of the irrigating fluid, 
urinary	extravasation,	UTI,	epididymitis,	urethral	diverticulum	and	bladder	neck	
contracture (Androulakakis et al. 2005, Sinha et al 2009, Sarhan et al. 2010). 
PROGRESSION TO END-STAGE RENAL DISEASE
Long-term	outcome	of	posterior	urethral	valves	has	not	been	properly	clarified.	
Early mortality has declined and consistently more patients with severe renal 
injury have survived (Dinneen and Duffy 1996). In accordance with this, many 
children with PUV develop ESRD, chronic irreversible renal failure, and require 
dialysis and renal transplantation. Of PUV patients, 5-64% end up with ESRD 
during childhood or adolescence (Roth et al. 2001). In paediatric age groups, the 
most	common	ages	to	develop	ESRD	have	been	concluded	to	be	the	first	year	of	life	
and adolescence (Smith et al. 1996). The follow-up in that study was not, however, 
extended	to	adulthood.	Some	patients	do	not	develop	chronic	renal	failure	and	
ESRD until adulthood (Uehling 1980, Parkhouse et al. 1988, Holmdahl and Sillén 
2005). Because late renal outcome has not been systematically analysed, the true 
late renal outcome is unknown.
PREDICTIVE FACTORS FOR END-STAGE RENAL DISEASE 
Traditionally,	age	at	presentation,	early	serum	creatinine	values	and	reflux	have	
been considered major risk factors for renal outcome in patients with PUV. 
Various other parameters have also been suggested to have an impact.  These 
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include pulmonary hypoplasia, urinary ascites, UTI, LUTD, renal echogenicity 
and proteinuria.  Evidence for these variables remains inconclusive.
Age at presentation
Early age at presentation is mostly regarded as a risk for later renal failure. 
Diagnosis before one year of age is a negative predictive factor of renal failure 
(Parkhouse et al. 1988, Kibar et al. 2011). Delayed presentation has historically 
been associated with a more benign clinical course (Hendren 1971, Parkhouse et 
al. 1988, Pieretti 1993). In contrast, a number of studies from several institutions 
have revealed that impaired renal function is associated with delayed diagnosis or 
that there is no difference among those diagnosed early or late (Tejani et al. 1986, 
El-Sherbiny et al. 2002, Ziylan et al. 2006, Ansari et al. 2010, Engel et al. 2011).  
Prenatal	diagnosis	has	been	anticipated	to	be	beneficial	for	infants	with	PUV	by	
facilitating early postnatal decompression, shortening the duration of obstruction 
and minimizing the risks of infective renal damage (Kousidis et al. 2008, Thomas 
2010). Accordingly, Dinneen et al. (1993) reported better renal function in the 
antenatally	diagnosed	group	during	the	first	year	of	life.	Reinberg	et	al.	(1992)	
failed to demonstrate clinical improvement in prenatally detected PUV relative 
to those with postnatal diagnosis. Moreover, Jee et al. (1993) found in their study 
that the outcome was worse in prenatally detected cases. 
Serum creatinine values
High	serum	creatinine	levels	at	presentation	and	especially	during	the	first	year	
after valve resection have been shown to be signs of poor renal prognosis in studies 
with a short or intermediate follow-up. Recently, Sarhan et al. (2010) noted a clear 
prognostic relation between initial serum creatinine and future renal function 
after a mean follow-up of 4.4 years. In accordance with this, high serum creatinine 
levels	at	diagnosis	and	during	the	first	year	after	valve	resection	indicated	poor	
prognosis in some previous reports (Uehling 1980, Denes et al. 1997, Drozdz 
et al. 1998, Oliveira et al. 2002, DeFoor et al. 2008).  Also postoperative nadir 
creatinine and serum creatinine at the age of one year have been shown to have 
prognostic	significance	(Denes et al. 1997, Drozdz et al. 1998, Ylinen et al. 2004, 
Sarhan et al. 2010). In addition, GFR initially and at the age of one year has been 
noted to have predictive value (Scott 1985, Lopez Pereira et al. 2003, Sarhan et 
al. 2011). In contrast, Bajpai et al. (2001) and Engel et al. (2011) in recent studies 
found	no	significant	correlations	with	initial	serum	creatinine	and	progression	
to chronic renal failure. Nevertheless, normal creatinine values at presentation 
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do	not	exclude	the	possibility	for	later	ESRD	(Denes	et	al.	1997,	Roth	et	al.	2001,	
Kousidis et al. 2008).
Vesicoureteral reflux
VUR is mostly considered a poor prognostic factor for overall renal function. Reflux,	
especially if bilateral, has been reported to carry a risk for renal deterioration 
(Tejani et al. 1986, Parkhouse et al. 1988, Denes et al. 1997, Roth et al. 2001, 
Oliveira et al. 2002, Ghanem et al. 2004, Ansari et al. 2010, Caione and Nappo 
2011, Engel et al. 2011). On the other hand, VUR has not been observed to indicate 
renal impairment in many other reports (Uehling 1980, Drozdz et al. 1998, Lopez 
Pereira et al. 2003, Kousidis et al. 2008, Kibar et al. 2011).
Unilateral	reflux,	especially	with	an	ipsilateral	non-functioning	kidney,	has	
been suggested to protect contralateral function. Hoover and Duckett (1982) 
postulated	that	this	association	spares	the	contralateral	non-refluxing	kidney	and	
ultimately renal function. Rittenberg et al. (1988) recognized this linkage of PUV, 
unilateral VUR and renal dysplasia (VURD), and presented two additional “pop-
off” mechanisms in PUV: urinoma and large congenital bladder diverticulum. 
These have been the topic of ample discussions in paediatric urological literature 
(Fernbach et al. 1990, Donnelly et al. 1997, Claahsen-van der Grinten et al. 2002, 
Oliveira et al. 2002, Lee et al. 2005, Wells 2010). In contrast, children with VURD 
in recent studies were observed to have impaired renal function (Cuckow et al. 
1997, Narasimhan et al. 2005). This is obviously not in line with a protective 
effect	of	VUR.		Sarhan	et	al.	(2011)	did	not	find	statistical	significance	between	
the	presence	or	absence	of	these	pop-off	mechanisms	and	final	renal	outcome.	
Urinary tract infection
UTIs have been associated with poor outcome and renal impairment in previous 
reports (Denes et al. 1997, Roth et al. 2001, Holmdahl and Sillén 2005, Narasimhan 
et al. 2005). Pyelonephritis is supposed to augment renal damage (Tejani et al. 
1986).	Ansari	et	al.	(2010)	and	Engel	et	al.	(2011)	did	not	find	clinical	UTIs	to	
be associated with chronic kidney disease progression. Denes et al. (1997) and 
Narasimhan et al. (2005), in turn, noted postoperative UTIs to have an adverse 
effect on later renal function. Pohl et al. (2012) reported that recurrent, i.e. more 
than three, UTIs are a risk factor for renal impairment.
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Incontinence and bladder dysfunction
Incontinence and LUTD have been reported to predict poor renal outcome in 
urethral valve patients in some reports. Parkhouse et al. (1988) observed that 
children	with	PUV	with	persisting	day-time	urinary	incontinence	at	the	age	of	five	
years had a worse renal function relative to those who were continent. Urinary 
incontinence and LUTD have also been reported to predict poor kidney function 
in PUV patients by others (Lopez Pereira et al. 2002, Holmdahl and Sillén 2005, 
DeFoor et al. 2008, Ansari et al. 2010).  Interestingly, Sarhan et al. (2008) did 
not	find	bladder	dysfunction	to	affect	final	renal	outcome.		No	relation	between	
urinary	incontinence	or	bladder	dysfunction	and	final	renal	outcome	was	seen	in	
some recent reports (Sarhan et al. 2008, Kousidis et al. 2008, Engel et al. 2011). 
Proteinuria
Parkhouse	et	al.	(1988)	and	Lopez	Pereira	et	al.	(2003)	identified	proteinuria	to	
be associated with poor long-term outcome. 
Other renal changes
US has been proposed to help in identifying patients with the highest risk for 
renal failure. Pohl et al. (2012) reported elevated echogenicity and pathological 
corticomedullary	differentiation	(CMD)	as	a	significant	risk	factors	for	decreased	
GFR. Normal renal echogenicity and CMD were considered useful in predicting 
good outcome (Duel et al. 1998, Sarhan et al. 2011). However, in some studies 
abnormal renal parenchymal echogenicity has been found to be relatively 
insensitive	and	poorly	specific	in	predicting	renal	failure	(Duel	et	al.	1998,	Lopez	
Pereira et al. 2003, Sarhan et al. 2011). 
RENAL TRANSPLANTATION
To	prevent	further	kidney	damage	in	PUV	patients,	proper	auxiliary	therapy	is	
of particular importance. With progression to ESRD, renal transplantation has 
been shown to offer good functional outcome even in patients with PUV (Bryant 
et al. 1991, Otukesh et al. 2008, Kamal et al. 2011). In addition, with adequate 
treatment the craft survival currently seems to be similar in PUV patients and 
non-urological patients (Otukesh et al. 2008, Kamal et al. 2011, Jesus and Pippi 
Salle 2015). However, a tendency for more frequent urinary tract infections and 
operative complications, such as urinary leakage and ureteral obstruction, in PUV 
patients has been reported (Kamal et al. 2011).  
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AIMS OF THE STUDY
PUV is a disorder that can cause serious consequences to the bladder and upper 
urinary tract. Despite advances in diagnosis and management, many patients 
progress to ESRD.  Although it is a rather rare disorder, it is one of the most 
common causes for renal transplantations in childhood.  The ultimate aim of this 
study is to improve awareness of PUV. By investigating risk factors, the prognosis 
and quality of life of PUV patients can be improved.
Specific	aims	were	as	follows:
1. to determine the progression of PUV to ESRD and the need for renal 
transplantations
2. to determine risk factors for poor kidney outcome
3. to determine the incidence of VUR in PUV patients and its association with 
primary kidney function and the spontaneous resolution of VUR
4. to determine the incidence of cryptorchidism and inguinal hernias in PUV and 
the association with primary kidney function
5. to evaluate the association of primary kidney function with voiding pressure 
and bladder capacity in infant patients  
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PATIENTS AND METHODS
PATIENTS AND METHODS
PATIENTS AND CONTROLS 
The hospital records of all patients treated for posterior urethral valves at 
Children’s Hospital, University of Helsinki, Helsinki, Finland, between 1953 and 
2003 were reviewed retrospectively. The diagnosis of PUV was based on voiding 
cystourethrography	and	confirmed	by	urethral	endoscopy	or	open	surgery	in	early	
series.	Two	hundred	patients	were	identified	and	serve	as	the	basis	for	Studies	I,	
II, IV and V. In addition, the hospital database for urodynamic studies and the 
case note archive were retrospectively reviewed for PUV patients from 1994 to 
2007.	Twenty-five	infant	patients	born	between	1994	and	2007	met	the	criteria	
of age less than 12 months at the time of valve ablation and a urodynamic study 
within 15 days of the procedure, and were evaluated for voiding pressure and 
bladder capacity (III).  These results were compared with a historical institutional 
control group, comprising male infants with a febrile UTI before the urodynamic 
investigation (Taskinen and Rintala 2007). Data on the deceased patients of 
the study material were sought from the Finnish Population Register Centre if 
the demise was not registered in hospital records. Patients undergoing dialysis 
treatment or transplantation were sought from patient records and the Finnish 
Kidney Transplantation Registry.  Data of study patients were retrospectively 
collected with special emphasis on age and mode at presentation, associated 
diseases,	existence	of	urinomas,	VUR,	surgical	treatment,	early	and	late	mortality	
and progression to ESRD.  Serum creatinine values at presentation and at follow-
up visits and primary scintigraphy were registered for evaluation of renal function. 
METHODS
CRYPTORCHIDISM AND INGUINAL HERNIAS (I)
Information concerning kidney function, VUR, and cryptorchidism and inguinal 
hernias was collected from hospital records. Testicular descent status and inguinal 
hernias were reported in 192 patients. Serum creatinine values at diagnosis and 
6 months postoperatively, primary renal split function and VUR in patients with 
undescended testes (UDT) and inguinal hernia were compared with those of 
patients without cryptorchidism and hernias.
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URINOMAS (II)
In	196	patients	with	sufficient	data	in	patient	charts	and	radiology	reports	at	the	
time of presentation, serum creatinine values at the time of diagnosis and 6 months 
postoperatively, primary renal split function and VUR were registered. Patients 
with urinoma were compared with patients of a similar age at presentation but 
without urinoma. Also incidence of end-stage renal failure during childhood was 
compared in both patient groups.
PRIMARY VOIDING PRESSURES AND KIDNEY FUNCTION IN INFANTS (III)
In the urodynamic evaluation of 25 infant patients, abdominal and bladder 
pressures and subtracted detrusor pressure were measured simultaneously using 
Ch4 feeding tubes and computerized equipment (Menuet, Dantec Co, Copenhagen, 
Denmark).	Bladder	filling	was	performed	via	a	separate	Ch4	feeding	tube	in	17	
cases	and	a	Ch5	suprapubic	catheter	in	8	patients.	The	first	urodynamic	evaluation	
was performed in 6 patients at a median of 3 (range 2 to 6) days before and in 
19 patients at 2 (range 0 to 15) days after valve ablation.  In 17 patients, the 
urodynamic studies were repeated after a median of 1.7 (range 1 to 3.5) months 
and after a median of 12.6 (range 6.7 to 20) months. 
Pmax	det	during	voiding	and	CBC	were	compared	with	those	of	earlier	institutional	
control group. The median age of the control group was 3.3 (range 1.5- 9.6) months. 
The urodynamic techniques in the control patients were similar to those in the present 
study. The voiding pressures were also compared with previous published reports of 
normal infants and infant patients with variable pathologies.
The serum creatinine values at presentation as well as at 6 and 12 months 
after valve ablation were compared with the urodynamic parameters. Also the 
occurrence of VUR and scintigraphic renal split function were compared with 
the urodynamic parameters. 
VESICOURETERAL REFLUX (IV)
Sufficient	data	to	confirm	VUR	at	presentation	were	available	for	197	patients.	In	
patients with VUR, the serum creatinine values at the time of diagnosis, at 6 and 
12 months and at 5 to 7 years postoperatively, and primary renal split function 
were compared with those of  patients without VUR. Also the incidence of end-
stage renal disease during childhood was compared in the same patient groups. 
The management and resolution of VUR were analysed in the whole series. 
Additionally, in patients born between 1980 and 2003 and initially treated at 
Children’s Hospital, University of Helsinki, the spontaneous resolution of VUR 
was analysed separately in detail.  
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LONG-TERM RISK OF END-STAGE RENAL DISEASE (V)
Seven patients died early and their renal function was not determined.  In the 
remaining	193	patients,	the	age	and	mode	at	presentation,	the	existence	of	VUR,	
urinomas	and	pneumothorax,	and	serum	creatinine	values	at	presentation	
and	during	the	first	year	after	the	release	of	the	obstruction	as	well	as	UTIs	
and incontinence during childhood were registered and compared with kidney 
outcome.  Progression to end-stage renal failure was assessed. The associations 
between primary serum creatinine values and patient age at onset of ESRD were 
analysed. Patients born before and after 1982, which was the threshold for prenatal 
ultrasound studies in this series, were also compared.
STATISTICS
The Mann-Whitney test was used to compare continuous variables between two 
groups	(I	–V)	and	the	Kruskal-Wallis	test	between	three	groups	(IV).	Fisher’s	exact	
test	was	used	to	compare	categorical	variables	(I,	II,	IV,	V).	Wilcoxon	signed-rank	
test was used to compare repeated measurements (III). Regression analysis was 
performed to evaluate associations between urodynamic parameters and serum 
creatinine levels or kidney split function and to test the association between the 
lowest	serum	creatinine	during	the	first	year	after	diagnosis	and	age	at	ESRD	
(III, V). Kaplan-Meier analysis was performed to evaluate the development of 
ESRD (V). 
Statistical analyses were carried out with the Statview software program 
(Statview®	5.0.1,	SAS	Institute	Inc.	Cary,	North	Carolina,	USA).	Significance	
was set at p<0.05.
ETHICS
The study protocol was approved by the Ethics Committee of Children’s Hospital 
and the Ethics Committee for Paediatrics, Adolescent Medicine and Psychiatry, 
University of Helsinki, Finland. 
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RESULTS
CRYPTORCHIDISM AND INGUINAL HERNIAS (I)
Cryptorchidism requiring operation was found in 31 (16%) of 192 patients, in 22 
(11%) unilaterally and in 9 (5%) bilaterally. In these 31 patients, the incidence 
of undescended testis was 16 (95% CI 11-21) -fold higher than in the normal 
Finnish population (Boisen et al. 2004). Right and left testicle in unilateral 
cryptorchidism was observed to have been retained equally often, in 11 patients 
each. In 29 patients, the location of the cryptorchid testis was reported, 25 testes 
were inguinal, 2 were suprascrotal and 2 were high scrotal. Tendency towards a 
more severe form of PUV in patients with cryptorchidism was observed, as their 
serum creatinine levels were higher and they more often had poor kidney function 
on one side than patients without cryptorchidism (Tables 1 and 2). In addition, 
UDT was more common among patients presenting earlier. Cryptorchidism was 
detected in 14 (27%) of 52 patients with a neonatal diagnosis of PUV and in 18 
(14%) of the 130 patients with a later diagnosis (p=0.027).  Of the 28 patients with 
an antenatal diagnosis of PUV, cryptorchidism was found in 3 (11%). Concomitant 
VUR was equally common in patients with and without cryptorchidism (22/31, 
71% vs. 103/158, 65%, respectively; p=0.679).
Inguinal hernias requiring operation not related to ipsilateral UDT were 
observed in 21 (11%) of 192 patients. Hernias were unilateral in 14 patients, 10 on 
the right side and 4 on the left, and bilateral in 7 patients. Hernias were found in 
18 (11%) of 161 patients without cryptorchidism and in 3 (10%) of 31 patients with 
UDT on the contralateral side. Higher serum creatinine levels at presentation were 
also measured in patients with inguinal hernias relative to those without hernias 
(mean 178 ±137 µmol/L vs. 110± 94 µmol/L, respectively, p=0.002; median 173, 
range 38-593 vs. 80, range 14-488, p= 0.003). However, serum creatinine levels 6 
months later and patient age at diagnosis were even in patients with and without 
hernias.
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RESULTS
Table 1. Age at presentation and differential function of worse kidney in cryptorchid and 
non-cryptorchid PUV patients. 
Patient age at presentation (years)
n Mean± SD Median Range p-value
Non-cryptorchid* 136 3.14± 4.41 0.70 0–25.52
Cryptorchid 28 1.49± 3.06 0.11 0–11.93 0.015
Differential function of the worse kidney (%)**
Non-cryptorchid 84 32± 17 40 0–50
Cryptorchid 22 21± 18 21 0–47 0.005
*The 28 patients with prenatal diagnosis were excluded from this analysis
**Function distribution of the worse kidney based on DTPA or DMSA scintigraphy
Table 2. Serum creatinine (s-crea) at presentation and 6 and 12 months later in PUV patients 
without and with cryptorchidism.
Non-cryptorchid Cryptorchid
s-crea (µmol/L) n median (range) n median (range) p-value
at presentation 106 87 (14–593) 21 100 (38–460) 0,131
at 6  months 60 45 (19–504) 13 90 (31–573) 0,006
at 12 months 68 46 (19–455) 18 52 (27–284) 0,524
URINOMAS (II)
Urinoma was detected in 17 (9%) of 196 patients. Four (4%) of 112 patients before 
the ultrasonography era from 1953 to 1979 and 13 (15%) of 84 patients later from 
1980	to	2003	had	extrarenal	urinary	extravasation.	Abdominal	distension	or	
palpable	mass	in	flank	was	registered	in	9	cases	with	urinoma.	The	remaining	8	
patients	had	an	incidental	finding	in	US	(6	patients)	or	x-ray	(2	patients).	PUV	
was diagnosed prenatally in 5 (29%) of 17 patients with urinoma and in 22 (32%) 
of 69 patients without urinoma.
The escape of urine took place in three separate anatomic locations. Perirenal 
urinoma was observed in 9 (53%) of 17 patients, 5 on the right and 4 on the left 
side.	Urinary	ascites	was	found	in	6	patients	(35%).	One	of	these	also	had	extensive	
retroperitoneal	urinoma.	Urinothorax	was	noted	in	2	patients	(12%),	both	having	
fluid	that	had	escaped	into	the	right	pleural	cavity.	
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All patients with urinoma were noted to have bilateral dilatation of UUT. 
Vesicoureteral	reflux	was	observed	in	11	(7	unilaterally,	4	bilaterally)	(69%)	of	
the 16 patients with urinoma and in 51 (76%) of the 67 control cases (p=0.536). 
Five (56%) of the 9 patients with perirenal urinoma had VUR. Three perirenal 
urinomas were located ipsilaterally and two contralaterally to VUR. In one patient 
with perirenal urinoma, VUR was not checked (a neonate who died from severe 
pulmonary hypoplasia at the age of 6 days). Five (83%) of the 6 patients with 
urinary	ascites	and	one	patient	with	urinothorax	also	had	VUR.
Values of serum creatinine measurements did not differ in patients with and 
without	urinoma	at	presentation	and	during	the	first	year	of	life	(Table	3).	Patients	
with perirenal urinoma had a median serum creatinine of 142 (range 54-204) 
µmol/L at presentation, and patients with urinary ascites had the same value, 142 
(range 73-395) µmol/L (p=0.558). The median creatinine values at 6 months after 
diagnosis were 48 (range 33-150) µmol/L in patients with perirenal urinoma and 
39 (range 31-230) µmol/L in patients with urinary ascites  (p=0.462).
Four (25%) of the 16 patients with urinoma and 16 (23%) of the 69 patients 
without urinoma progressed to ESRD during childhood.
In 6 patients with perirenal urinoma (4 patients with urinary ascites, 2 
boys	with	urinothorax),	DTPA	scintigraphy	was	done	and	renal	split	function	
was analysed. In patients with urinoma, split function of 51% (range 38-70%) 
ipsilaterally was observed. The function was lower on the side of urinoma in 2 
patients and on the contralateral side in one patient. The remaining 3 patients 
had similar kidney function on both sides. Three of the patients with ascites had 
reduced kidney function on one side (0%, 9% and 33%, respectively).  The patients 
with	urinothorax	had	a	split	function	distribution	of	65%	and	34%	on	the	side	of	
pleural effusion. 
Bladder drainage was established postnatally in all patients after the detection 
of urethral obstruction. In addition, ureterocutaeostomy was performed on 13 
patients. The pleural cavity was drained with needle aspiration in one patient and 
with	a	chest	tube	in	the	other	patient	with	urinothorax.  Two patients, one with 
urinoma and the other with ascites, underwent primary nephrectomy.
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RESULTS
Table 3. Serum creatinine (s-crea) at presentation, 6 and 12 months later and nadir during 
the first year after diagnosis in PUV patients without and with urinoma.
No urinoma          Urinoma
s-crea (µmol/L) n median (range) n median (range) p-value
at presentation 56 126 (19-593) 14 145 (54-431) 0,547
at 6 months 43 46 (19-573) 10 46 (31-230) 0,725
at 12 months 44 48 (22-455) 10 45 (33-154) 0,548
nadir value 49 43 (18-573) 11 43 (22-230) 0.848
PRIMARY VOIDING PRESSURES AND KIDNEY FUNCTION IN 
INFANTS (III)
Primary bladder capacity was a median of 22 (range 5-125) ml in PUV patients and 
38 (range 6-129) ml in the control group (p=0.061) at a median age of 0.5 (range 
0-10.2) months and 3.3 (range 1.5-9.6) months, respectively. The CBC values 
showed considerable variation among individuals. The measurements before 
and	after	abolition	of	valves	did	not,	however,	differ	significantly.	In	addition,	in	
patients with or without VUR the CBC values were similar (Figure 4). 
Pmax	det	values	during	voiding	also	showed	marked	interindividual	variation.	
Primary	median	Pmax	det	values	of	patients	and	controls,	112	(range	40-331)	cmH2O 
and 91 (range 48-191) cmH2O,	respectively,	did	not	differ	significantly	(p=0.397).	
Pmax	det	levels	in	the	primary	urodynamic	studies	in	patients	before	or	after	valve	
ablation, as with or without VUR, were of the same magnitude (Figure 4). Measured 
Pmax	det	values,	although	high,	were	consistent	with	the	pressure	levels	in	male	
infants with variable diagnoses in previous studies (Holmdahl et al. 1995, Sillén et 
al. 1996, Bachelard at al. 1998, 1999, Yeung et al. 1998, Ichino et al. 2007).
A	follow-up	urodynamic	study	after	one	month	revealed	an	insignificant	
increase in median bladder capacity from 22 (range 5-125) ml to 23 (range 9-169) 
ml	(p=0.278)	and	an	insignificant	decrease	in	median	maximal	voiding	pressure	
from 112 (range 40-331) cmH2O to 102 (range 53-300) cmH2O (p=0.196).  By 
contrast,	one	year	after	abolition	of	the	valves	there	was	a	significant	increase	in	
median	bladder	capacity	to	112	(range	40-256)	ml	and	a	significant	decrease	in	
median	maximal	voiding	pressure	to	100	(range	60-193)	cmH2O (p<0.001 and 
p=0.011, respectively). 
No	significant	association	was	present	between	Pmax	det	and	serum	creatinine	
levels at the time of diagnosis or at the 6-month follow-up (R=-0.271, p=0.200 and 
R=-0.224, p=0.304, respectively). However, the patients with the highest serum 
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creatinine levels had relatively low voiding pressures, whereas the patients with the 
highest voiding pressures had rather low serum creatinine values (Figure 5). No 
association	existed	between	high	voiding	pressures	and	unilateral	poor	functioning	
kidney. Neither was there a correlation between CBC values at presentation and 
serum	creatinine	levels	during	the	first	year	of	life.	
Again,	no	significant	correlation	was	observed	between	bladder	capacity	and	
maximal	voiding	pressures	in	PUV	patients	(R=	-0.093,	p=0.665),	but	a	significant	
negative correlation was found in the control group (R= -0.497, p=0.031).
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Figure 4. Urodynamics in infant PUV patients around valve ablation. Cystometric bladder 
capacity (CBC) and maximal detrusor pressure during voiding (Pmax det). VUR-/VUR+ = 
patients without/with VUR.     
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RESULTS
Figure 5. Maximal detrusor pressures during voiding (Pmax mict) at the time of valve 
ablation and serum creatinine values (s-crea) at presentation. 
VESICOURETERAL REFLUX (IV)    
Vesicoureteral	reflux	was	confirmed	in	127	(64%)	of	197	patients.	VUR	was	bilateral	
in	73	patients	(37%)	and	unilateral	in	54	(27%).	Unilateral	reflux	was on the right 
side in 31 patients (57%) and on the left side in 23 (43%). VUR was grade V in 116 
(59%), grade IV in 47 (24%), grade III in 16 (8%), grade II in 4 (2%) and grade I in 
4 (2%) ureters.  Median age at presentation of PUV was 0.3 (range 0-25.5) years. 
Of the 99 postnatally presented patients, the diagnosis was made at a younger 
age in those with VUR than without VUR (median ages 0.3 (range 0-14.6) years 
and	2.9	(range	0-25.5)	years,	respectively,	p<0.001).	Reflux	was	registered	in	17	
(61%) of the 28 patients with an antenatal diagnosis of PUV.
At	the	time	of	diagnosis,	refluxing	patients	had	significantly	higher	serum	
creatinine levels than patients without VUR (Table 4). This was a conspicuous 
finding	particularly	in	bilateral	VUR,	in	which	the	significance	persisted	at	the	6-	
and	12-month	follow-ups.		In	addition,	ESRD	developed	significantly	more	often	
in	patients	with	bilateral	reflux.
Primary	scintigraphy	revealed	also	a	very	poor	kidney	on	the	refluxing	side,	with	
split function of less than 10% in 22 (30%) of the 73 patients investigated.  Of the 
35 patients without VUR, 2 (6%, p= 0.006) had such poorly functioning kidneys 
in scintigraphy. The median split function of worse	kidney	was	significantly	lower	
not only in unilateral VUR cases but also in bilateral cases than in patients without 
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VUR (Table 4). In	unilateral	cases,	the	median	split	function	on	the	refluxing	side	
was 31% (range 0-58) and on the contralateral side 69% (range 42-100) (p<0.001).
In	the	early	series,	11	refluxing	ureters	in	10	patients	were	operated	on	before	or	
at the time of valve ablation. In 4 patients, nephrectomy was done elsewhere prior 
to admission to our hospital and valve ablation. In another 5 patients unilateral, 
and in one patient bilateral ureteral reimplantation was performed. 
Follow-up	data	were	available	for	141	refluxing	ureters,	while	49	ureters	were	
lost to follow-up or documentation was inadequate. In 88 ureters (62%), VUR 
resolved	spontaneously,	in	29	ureters	(21%)	following	antireflux	surgery	and	in	
24 ureters (17%) after nephrectomy. 
Over the long study period, VUR in PUV patients has been subjected to 
different	treatment	options.	Ureterovesical	surgery	was	done	almost	exclusively	
early in the series or elsewhere before referral to our hospital. Nephrectomies 
were performed in cases with non-functioning or only marginally functioning 
kidneys where massive VUR usually persisted. Unilateral nephrectomy in patients 
with	ipsilateral	massive	reflux	and	non-functioning	kidney	was	performed	on	35	
patients (18%), 18 on the right side and 17 on the left. VUR had resolved, however, 
in 11 of the 35 cases before nephrectomy. Of patients with unilateral and bilateral 
VUR, nephrectomy was performed on 20 (37%) and 15 (21%) cases, respectively. 
Also 3 (4%) of the 70 patients without VUR were submitted to nephrectomy. 
Resolution of VUR was observed in a median of 1.28 (range 0.04-15.16) years 
after release of urethral obstruction in those ureterorenal units not subjected to 
reimplantation or nephrectomy.  The elapsed time in 24 patients with unilateral 
reflux	was	0.71	(range	0.04-7.93)	years	and	in	64	patients with	bilateral	reflux	
1.36	(range	0.04-15.16)	years	(p=0.049).	No	correlation	existed	between	kidney	
split function and resolution of VUR (r=0.19, p=0.37). However, resolution was 
noted	to	be	faster	in	grade	I-III	than	in	grade	IV-V	reflux,	with	a	median	of	0.68	
(range 0.14-15.16) years and 1.47 (range 0.04-15.16) years, respectively (p=0.054).
In the 68 patients born between 1980 and 2003 and primarily treated in our 
hospital,	20	had	unilateral	and	19	bilateral	VUR.	Of	these	58	refluxing	ureters,	
31%	resolved	during	the	first	and	19%	during	the	second	year	after	release	of	
urethral obstruction (Table 5). 
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Table 4. Serum creatinine levels (mean± SD, median (range)) at presentation and at 6 and 
12 months after resection of PUV in patients without VUR (Group 1), with unilateral VUR 
(Group 2) and with bilateral VUR (Group 3).
Group 1 Group 2 Group 3
  n mean±SD
median 
(range)
n mean±SD
median 
(range)
n mean±SD
median (range)
p-value
<0.05
S-crea (µmol/L)
at presentation
45 87± 67
66 (19–374)
39 144± 125
97 (21–433)
47 155± 122
130 (14–593)
Gr 1 vs. 
Gr 2 and Gr3
S-crea (µmol/L)
at 6 months 
postoperation  
25 50± 43
43 (19–229)
23 83± 114
 43 (22–504)
26 116± 128
58 (20–573)
Gr 1 vs. Gr 3
S-crea (µmol/L)
at 12 months 
postoperation
30 50± 46
43 (19–284)
28 79± 96
46 (22–455)
29 90± 66
57 (28–292)
Gr 1 vs. Gr 3
Split renal function (%)
on worse kidney 
35 40± 12
45 (0–50)
34 26± 19 
31 (0–49)
39 25± 17
29 (0–50)
Gr 1 vs. 
Gr 2 and Gr3
Table 5. Cessation of VUR after ablation of PUV in 58 ureters in 39 patients born in 1980-
2003.
Follow-
up 
(years)
Spontaneous 
resolution of 
VUR 
n (%)
Cumulative 
spontaneous 
resolution
%
Nephrectomy
n (%)
Antireflux 
surgery
n (%)
Persisting VUR  
at last control
n (%)
0-1 18 (31.0) 31 1 (1.7) 0
1-2 11 (19.0) 50 5 (8.6) 0
2-3 5 (8.6) 59 1 (1.7) 0 4 (6.9)
3-4 1 (1.7) 60 0 1 (1.7) 1 (1.7)
4-5 1 (1.7) 62 0 1*(1.7)
5-6 1 (1.7) 64 0 0
6-7 0 0 0
7-8 0 2 (3.4) 0
8+ 2 (3.4) 67 0 0 3 (5.2)
*Deflux® injection to ureteric orifice
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LONG-TERM RISK OF END-STAGE RENAL DISEASE (V)
Of the 193 PUV patients, 44 (22.8%) progressed to ESRD at the median follow-up 
age of 31 (range 6-69) years. Thirty (68%) of these 44 patients with ESRD had 
progression before the age of 17 years and 14 patients (32%) later. Renal failure 
was the cause of death in 9 patients (4.6%), in 2 under the age of one year, in 3 at 
the age of 4 years and in 4 between the ages of 12 and 17 years. The highest age 
at onset of ESRD was 34 years, while 59 of the patients were older than that but 
without ESRD at the time of evaluation.  The probability of developing ESRD 
during the life-time according to Kaplan-Meier analysis was 28.5% (SE 3.8%, 
Figure 6). 
The cumulative risk for ESRD was 16.7% (SE 3.4%) before the age of 27 years 
in the early series of 121 patients born between 1953 and 1981 before the prenatal 
US era and 36.6% (SE 7.7%) in the later series of 72 patients born between 1982 
and 2003 (Figure 6). In the Kaplan-Meier survival plot, the probability of ESRD 
was 54.8% (SE 14.1%) in patients with an antenatal diagnosis, 31.9% (SE 14.1%) 
in patients with early neonatal problems and 22.1% (SE 10.0%) in patients with 
infection at presentation (Figure 7). In the series from the US era, 28 patients 
had an antenatal diagnosis and 44 a postnatal diagnosis. In this late cohort, 10 
patients (36%) in the antenatal group and 7 patients (14%) in the postnatal group 
developed ESRD (p=0.047). 
Primary	serum	creatinine	values	were	significantly	higher	in	the	28	patients	
contracting end-stage renal failure than in the 100 non-ESRD-developing patients, 
with median values of 173 (range 46-593) µmol/L and 70 (range 14-460) µmol/L, 
respectively (p < 0.001).  Also the lowest creatinine values during the first 
postoperative	year	were	significantly	higher	in	the	24	patients	progressing	to	ESRD	
than in the 74 non-ESRD-developing ones (median 134 (range 45-573) µmol/L 
and 38 µmol/L (range 14-97) µmol/L, respectively, p<0.001). All patients with 
nadir	creatinine	above	97	µmol/L	during	the	first	year	after	diagnosis	developed	
ESRD, whereas no patient with serum creatinine less than 45 µmol/L progressed 
to	ESRD.	In	addition	nadir	creatinine	during	the	first	postoperative	year	was	
observed to be associated with the speed of progression of ESRD.
Those	patients	who	had	pneumothorax	or	bilateral	VUR	at	presentation	
or	recurrent	UTIs	after	abolition	of	valves	had	significantly	increased	risk	for	
ESRD at follow-up (Table 6). However, urinoma or unilateral VUR at the time 
of diagnosis or delayed urinary continence did not show such a risk for ESRD 
(Table 6, Figure 8).
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Figure 6. Kaplan-Meier analysis. Renal survival of patients born in 1953-1981 and  
in 1982–2003. 
Figure 7. Kaplan-Meier analysis. Renal survival of patients with different modes of 
presentation.
 121 114 101 81 44 11
 72 52 15
 193 166 116 81 44 11
 28 17 4
 96 90 69 48 29 7
 31 25 15 8 2 
 38 34 28 25 13 4
 193 166 116 81 44 11
Early series 
1953–1981
Late series 
1982-2003
All
All
45
Figure 8. Kaplan-Meier analysis. Presence of VUR at diagnosis and renal survival.
Table 6. Characteristics and their relation to ESRD in PUV patients.
  All (n=193) No ESRD (n=149) ESRD (n=44)    p-value
Urinoma 17/193    (8.8%) 14/149   (9.4%) 3/44   (6.8%)    0.767
Pneumothorax 10/193   (5.2%) 3/149   (2.0%) 7/44 (15.9%)    0.002
VUR 123/192 (64.1%) 88/149 (59.1%) 35/43 (81.4%)    0.007
   Bilateral 72/192 (37.5%) 45/149 (30.2%) 27/43 (62.8%)   <0.001
   Unilateral 51/192 (26.6%) 43/149 (28.9%) 8/43 (18.6%)    0.240
Recurrent UTIs
postoperation 
35/193 (18.1%) 19/149 (12.8%) 16/44 (36.4%)   <0.001
Enuresis (after 
age of 5 years)
70/193 (36.3%) 55/149 (36.9%) 15/44 (34.1%)   >0.99
 69 60 44 34 17 3
 51 47 32 22 13 4
 72 58 40 25 14 4
 193 166 116 81 44 11All
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The incidence of cryptorchidism in our patients was 16%. It has previously been 
reported to be 12% among boys with PUV (Krueger et al. 1980b). In another 
report, 17% undescended testes were originally found in conjunction with PUV 
(Barker et al. 1993).  In this latter series, patients with prune belly and Noonan 
syndromes were, however, included, and when these syndromes were removed the 
figure	dropped	to	12%	(Barker	et	al.	1993).		In	a	recent	unselected	Finnish	male	
population, the incidence of cryptorchidism was 1.0% at the ages of both 3 and 18 
months (Boisen et al. 2004). In our PUV patients, the risk rate of cryptorchidism 
was therefore 16-fold higher. UDT occurred bilaterally in 29% of cases. This 
exceeds	the	20%	reported	in	an	unselected	cryptorchid	population	and	in	one	
of the earlier studies with PUV (Boisen et al. 2004, Barker et al. 1993), but is 
somewhat less than the 42% found in the other PUV study (Krueger et al. 1980b). 
Our patients with cryptorchidism had a more severe form of PUV. The diagnosis 
of PUV was made earlier and kidney function was worse in the cryptorchid group. 
In the earlier reports, undescended testes were also more common in patients 
with a neonatal diagnosis and obviously in those with more severe PUV (Krueger 
et	al.	1980b,	Barker	et	al.	1993).		This	finding	makes	it	appealing	to	propose	
that urethral obstruction per se constitutes the failure in testicular migration. 
Earlier, in foetuses with PUV, the amount of foetal germ cells has been noted 
to be reduced (Orvis et al. 1988).    Testicular endocrinopathies have not been 
reported in PUV patients after puberty (Puri et al. 2002).    In this retrospective 
study,	hormonal	measurements	were	not	done.	Thus,	definitive	conclusions	about	
whether diminished renal function and adverse effects on hormonal balance or 
mechanical reasons are responsible for PUV cannot be drawn. 
The incidence of inguinal hernias in our patients (11%) was higher than in 
the general child population (1.5%) (Yücesan et al. 1993).  The 7-fold incidence 
may have the same aetiological background as cryptorchidism in PUV patients. 
Inguinal hernias were found to be associated with severe forms of PUV, but not 
as strongly as cryptorchidism.
The incidence of urinomas among PUV patients in our series was 9%. It is 
just	slightly	higher	than	the	previously	reported	1-8.5%	(Greenfield	et	al.	1982,	
Rittenberg et al. 1988, Patil et al. 2003). In the early series in our study before 
the time of ultrasonography, only 4% of the patients were found to have urinoma. 
After US became routine in clinical use, 15% of the PUV patients were detected to 
have	urinoma.	The	latter	figure	probably	reflects	the	advantage	of	US	studies	in	
diagnostics and indicates the true incidence at the moment. In a recent US study, 2 
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of	8	patients	were	found	to	have	a	perirenal	fluid	collection	(Donnelly	et	al.	1997).	
Urinoma, previously regarded as a rare complication of PUV, has proven to be 
more	common.	In	the	present	study,	reflux	was	seen	in	69%	of	the	patients	with	
perirenal urinoma and in 83% of the patients with urinary ascites, and even in 
one	of	2	patients	with	urinothorax.	In	a	previous	report,	VUR	has	been	concluded	
to be a companion of perirenal urinoma, but not of urinary ascites (Patil et al. 
2003).	This	argument	is	contrary	to	our	findings.	
Urinomas have been proposed to protect overall renal function in many 
reports (Kay et al. 1980,  Rittenberg et al. 1988, Fernbach et al. 1990, Donnelly et 
al. 1997, Lee et al. 2005).  In recent studies, this statement has been questioned 
(Patil et al. 2003, Kleppe et al. 2006).  Renal function has actually even been 
described as impaired on the side of the perirenal urinoma (Patil et al. 2003). 
Our	findings	did	not	show	any	particular	benefit	or	harm	from	urinomas	to	
renal function. Two of our patients had somewhat lower function on the side 
of the urinoma and one on the contralateral side. Kidney function of patients 
with urinomas and controls did not differ as a rule.  Liability to more severe 
obstruction	cannot,	however,	be	excluded.	
After primary drainage, 3 patients were managed with valve ablation only in our 
series,	13	patients	had	ureterocutaneostomy	and	both	patients	with	urinothorax	
had drainage of the pleural cavity. Whether all procedures were actually necessary 
cannot	be	definitively	ascertained	from	this	retrospective	material.	In	a	recent	
report, bladder drainage and observation were preferred, and aspiration was 
deemed to be indicated only in symptomatic urinomas (Patil et al. 2003). Only in 
2 of 18 cases was nephrostomy or ureterostomy performed in that study.
In our series, only symptomatic cases of urinomas were detected and treated 
with temporary diversion. Urinary diversion in these patients was seen to augment 
effective stabilization of the overall condition. Currently, however, more urinary 
extravasations	may	be	observed	and	only	unsatisfactory	clinical	course	after	initial	
bladder drainage may demand additional interventions, as was concluded by 
Patil et al. (2003).
In PUV patients, dysplastic changes in kidneys have been proposed to be 
caused by abnormal development of ureteric bud or bladder outlet obstruction 
itself	(Gonzalez	et	al.	1990,	Farrugia	et	al.	2007).	In	experimental	models, severe 
bladder outlet obstruction has been observed to lead to renal dysplasia (Gonzalez 
et al. 1990, Farrugia et al.	2007).		Infravesical	obstruction	in	a	recent	experimental	
foetal ovine study caused an increase in the duration and frequency of elevated 
voiding pressures (Farrugia et al. 2007).  Foetal kidney development was disturbed 
by altered bladder dynamics in that study. Also in infant PUV patients marked 
detrusor hypercontractility together with high voiding pressures have been 
observed (Holmdahl et al. 1995). The high voiding pressures found in our study 
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are consistent with that observation. Similar high voiding pressures, however, 
were detected in our control group of boys with previous UTI as well as in healthy 
male	infants	with	UTI	and	reflux	in	earlier	reports	(Sillén	et	al.	1996,	Bachelard	et	
al. 1998, 1999, Yeung et al. 1998, Ichino et al. 2007). The long narrow infant male 
urethra and dyscoordination between the bladder and sphincter are assumed to 
cause these high voiding pressures (Sillén and Hjälmås 2004). 
We	could	confirm	a	decline	in	voiding	pressures	after	valve	ablation,	but	a	
significant	change	was	not	noted	until	one	year	later.	A	gradual	decrease	in	voiding	
pressures has been reported also among other male infant groups (Holmdahl et al. 
1995, Sillén et al. 1996, Ichino et al. 2007).  The somewhat higher voiding pressures 
in our PUV patients relative to controls may, in addition to obstruction by valves, 
also result from the slightly younger age of the PUV patients. In addition, there 
was	significant	interindividual	variation	between	voiding	pressures	in	our	study,	
as in other studies with infants (Sillén et al. 1996, Bachelard et al. 1998, 1999).
We	were	unable	to	detect	a	relation	between	Pmax	det	and	CBC	and	serum	
creatinine levels at the time of diagnosis or during the year thereafter.  This does 
not,	however,	exclude	the	possible	prenatal	participation	in	voiding	pressures.	
Moreover,	Pmax	det	may	not	be	the	most	accurate	indicator	of	the	pressure	effects	
in UUT. The study design did not allow us to measure the duration and frequency 
of high intravesical pressure periods, which have been regarded as essential for 
adverse effects on the foetal kidney (Farrugia et al. 2007). For this type of analysis, 
a	naturally	filling	cystometry	is	obviously	required	since	hypercontractile	bladders	
of PUV patients have been shown to become stable during sleep (Holmdahl et 
al. 1997).  Noteworthy	is	that	there	was	a	peculiar	non-significant	trend	towards	
higher voiding pressures in patients with better kidney function.
In	our	study,	the	maximal	voiding	pressures	did	not	differ	in	patients	with	and	
without VUR. A similar observation has previously been reported (Holmdahl et al. 
1995). In our study, also the measured bladder volume did not differ in patients 
with	and	without	VUR.	In	refluxing	patients,	measurement	of	bladder	volume	
without videocystometry may, however, be imprecise. 
In	our	study,	64%	of	all	PUV	patients	had	vesicoureteral	reflux.		This	is	in	
accordance with earlier reports, with VUR occurring in 26-72% of boys with PUV 
(Dinneen and Duffy 1996). VUR was bilateral in 37% and unilateral in 27% of 
cases in the present series, which is in line with previous albeit smaller series, with 
bilateral VUR ranging from 32% to 37% and unilateral VUR from 25% to 35% 
(Johnston 1979, Priti et al. 2004). VUR especially bilaterally in PUV patients has 
been observed to accompany impaired overall kidney function (Johnston 1979, 
Tejani et al. 1986, Parkhouse et al. 1988, Denes et al. 1997, Oliveira et al. 2002). 
In	our	study,	the	serum	creatinine	levels	at	presentation	were	significantly	higher	
in VUR patients than in non-VUR patients. Serum creatinine levels also remained 
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high	during	the	first	year	in	patients	with	bilateral	VUR	and	to	a	lesser	degree	in	
those with unilateral VUR. These values were still higher 5-7 years after ablation 
of valves in patients with VUR. The great majority of patients who progressed to 
ESRD during childhood had VUR, mostly bilaterally. The postnatally detected 
refluxing	patients	were	also	younger	at	the	time	of	diagnosis	than	those	without	
VUR. Younger age at presentation as well as impaired kidney function before and 
after valve ablation have been shown to indicate late poor renal function (Scott 
1985, Drozdz et al. 1998, Lopez Pereira et al. 2003). 
Previously, a high incidence of non-functioning kidneys has been noted in cases 
with	ipsilateral	VUR	(Hoover	and	Duckett	1982,	Greenfield	et	al.	1983,	Donnelly	
et	al.	1997).	In	these	patients,	non-functioning	kidneys	and	refluxing	units	have	
been reported to occur more commonly on the left side. A pop-off mechanism 
has been speculated to protect the contralateral side (Hoover and Duckett 1982, 
Greenfield	et	al.	1983,	Donnelly	et	al.	1997,	Oliveira	et	al.	2002).	The	concept	that	
unilateral	reflux	protects	the	contralateral	kidney	is	not,	however,	supported	by	all	
authors (Cuckow et al. 1997, Drozdz et al. 1998, Lopez Pereira et al. 2003). In our 
study,	the	contralateral	split	function	was	significantly	higher	than	that	on	the	VUR	
side.  The overall kidney function did not, however, differ or it was only slightly 
reduced in patients with unilateral VUR relative to those without VUR. These 
findings	thus	do	not	lend	support	for	a	protective	pop-off	effect.	In	patients	with	
VUR, we did not detect left-side dominance in non-functioning kidneys. Of the 
35 removed non-functioning kidneys, 18 were on the right and 17 on the left side.
After abolition of valves, VUR is known to resolve in many patients. Johnston 
reported	resolution	of	reflux	in	30	(46%)	of	65	ureters	in	44	patients	during	a	
follow-up lasting from 2 weeks to 13 months (Johnston 1979). More recently, VUR 
has	been	reported	to	resolve	in	27-40%	of	refluxing	ureters	after	a	follow-up	of	
1-21 years (Scott 1985, Lal et al. 1998b, Farhat et al. 2000), and in 64% of patients 
with PUV during a mean follow-up of 6.3 years after treatment of valves (Connor 
and Burbige 1990). In our study, VUR was observed to resolve in 62% of ureters 
in a median of 1.28 (range 0.04-15.16) years after valve resection. In unilateral 
cases,	VUR	subsided	significantly	sooner	than	in	bilateral	cases.	
Vesicoureteral	reflux	in	PUV	patients	is	presumably	secondary	to	infravesical	
obstruction.		Thus,	after	ablation	of	valves	resolution	of	VUR	is	expected.		The	rate	
of spontaneous resolution of VUR was not affected by the kidney split function 
in the present study, and in 11 ureters VUR subsided even on the side of the non-
functioning	kidney.	Resolution	of	reflux	in	a	non-functioning	unit	has	been	shown	
before	(Kim	et	al.	1997).	Low-grade	reflux,	however,	showed	a	trend	towards	
faster resolution in our series. A weakness of our retrospective analysis is that 
radiographs and radionuclide cystographies after valve ablation were not done 
following a consistent regimen but after individualized timetables, particularly 
in the early series.
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Auxiliary	operative	procedures	were	performed	on	numerous	patients	with	
VUR.	Antireflux	surgery	was	carried	out	for	21%	and	nephrectomy	for	17%	of	
refluxing	ureters.	In	many	early	cases,	indications	for	these	surgical	procedures	
could	not	be	defined	accurately	and	also	the	operative	techniques	had	varied	
over time. There is evidence that reimplantations are liable to hazards, with 
complication rates of 45-67% described in PUV patients (Atwell 1983, Tejani et 
al. 1986). However, ureteral surgery has its proponents, although the results do 
not	necessarily	reach	expectations	at	present	(El-Sherbiny	et	al.	2002).	Practically	
all reimplantations in our study material were performed in the early series or 
elsewhere	before	referral	to	our	hospital.	Since	antireflux	surgery	was	utilized	
mostly	rather	soon	after	abolition	of	valves,	it	may	be	justified	to	conclude	that	
some of the procedures might not have been necessary. 
We also analysed separately the spontaneous resolution rate of VUR after 
ablation	of	PUV	in	the	late	series	(39	patients)	with	more	standardized	x-ray	and	
isotope studies. In that cohort, 57% had VUR, and it subsided in 31% and 50% of 
the	refluxing	ureters	after	a	follow-up	of	one	and	two	years,	respectively.	In	67%	
of the units, VUR resolved by 8 years. We have very seldom found indications for 
ureteral reimplantation. 
In patients with persistent VUR and recurrent UTIs, or marginally functioning 
kidneys after valve resection, we start clean intermittent catheterizations (CIC), 
or perform ring-type temporary supravesical diversions. In these severely ill 
patients, also others have suggested CIC and vesicostomy or ureterocutaneostomy 
to control infection and stabilize the overall situation (Denes et al. 1997, Farhat 
et al. 2000, Liard et al. 2000, Haecker et al. 2002, Ghanem and Nijman 2005). 
In the present series, the few older patients with persistent VUR did not have 
recurrent UTIs or compromised renal function, and successive cystograms were 
not	considered	justified.
A non-functioning kidney with VUR is thought to be susceptible to disturbances 
of bladder function and UTIs. In the present study, we were not able to test this 
concept, but in many patients bouts of pyelonephritis were seen as a contributory 
factor when considering indications for nephrectomy. The incidence of unilateral 
nephrectomies in our series was 18%, which is in line with the previously reported 
17-19% (Atwell 1983, Cuckow et al. 1997, Holmdahl and Sillén 2005). Nephrectomy 
in	these	situations	can	be	deemed	justified.	
To our knowledge, this is the largest systematic study with the longest follow-
up to assess the progression of ESRD in patients with PUV.  The onset of ESRD 
was	defined	as	the	start	of	dialysis	or	the	date	of	death	to	chronic	uremia.	Nearly	
one-fourth (22.8%) of these 193 patients progressed to ESRD during a median 
follow-up of 31 years. Of the ESRD patients, about two-thirds (68%) had the 
progression as a child before the age of 17 years and one-third (32%) as an adult. 
Early	diagnosis,	high	primary	serum	creatinine	values,	pneumothorax,	bilateral	
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VUR at presentation and recurrent UTIs after abolition of the valves were related 
to poor prognosis. The calculated life-time risk for ESRD was 28.5%. However, in 
the early series among those born before 1982 in the pre-sonography era, the risk 
for ESRD was only 16.8% before the age of 27 years. In turn, among those born 
later in the post-sonography era, the risk for developing ESRD before the age of 
27 years was 36.6%. Accordingly, also true life-time risk presumably will rise. A 
better	outcome	in	the	early	series	was	obvious,	and	a	likely	explanation	is	that	
many critically ill patients died without referral to our hospital.  In addition, in 
the later series there may be burden of severely ill patients since ours is the only 
hospital performing renal transplantations for children in our country. 
The most common ages for developing ESRD in PUV patients have been 
concluded	to	be	the	first	year	of	life	and	adolescence.	(Smith	et	al.	1996)	The	
follow-up in that study, however, included only children. We could verify that 
the progression was rather steady up to the age of 34 years, and only a moderate 
slope	was	seen	in	the	progression	during	the	first	year	of	life	and	in	adolescence.	A	
recent study from Sweden disclosed that 32% of their 19 adult patients developed 
uraemia, the oldest at the age of 37 years (Holmdahl and Sillén 2005). The oldest 
patient progressing to ESRD in our series was 34 years. Since 59 of our patients 
had	achieved	ages	higher	than	that,	it	may	be	justified	to	predict	that	progression	
to chronic renal failure diminishes with age.
Maternal US screening offers a notable advantage in diagnosing posterior 
urethral valves (Roth et al. 2001).  With the advent of prenatal diagnosis, it was 
anticipated	that	the	greatest	benefit	would	be	for	infants	with	PUV	by	facilitating	
early postnatal decompression, shortening the duration of obstruction and 
minimizing the risks of infective renal damage (Thomas 2010). Prenatal recognition 
and early management of asymptomatic patients have been shown to improve 
final	outcome	in	some	reports	(Kousidis	et	al.	2008,	Thomas	2010).		However,	
some studies have failed to demonstrate that outcome is better with prenatal 
presentation (Yohannes and Hanna 2002, Hodges et al. 2009).  We could show 
higher	risk	for	ESRD	in	patients	with	an	antenatal	diagnosis.	A	likely	explanation	
for	this	finding	is	that	the	most	severe	cases	were	more	often	detected	prenatally.	
Our observation is in line with earlier studies with a shorter follow-up (Reinberg 
et al. 1992, Jee et al. 1993). The rather liberal policy to terminate pregnancies with 
obstructive	uropathies	in	some	countries	can	impact	the	renal	survival	figures.	
In the present study, there was no selection in this respect since the termination 
of pregnancy due to PUV is very rare in our country. Most antenatal cases in this 
work were detected at screening during gestation weeks 18-20.
In	our	study	with	a	very	long	follow-up,	we	could	confirm	that	serum	creatinine	
values at presentation and during the following year have a correlation with 
prognosis. This observation is consistent with earlier studies with shorter follow-
ups (Denes et al. 1997, Drozdz et al. 1998, Oliveira et al. 2002, DeFoor et al. 2008). 
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Furthermore, we were able to verify that primary serum creatinine values have an 
impact on the speed of progression to ESRD. Rather low serum creatinine values 
at	presentation	in	our	study	did	not	exclude	later	ESRD,	a	finding	in	agreement	
with some earlier reports with shorter follow-ups (Roth et al. 2001, Kousidis et 
al. 2008, Denes et al. 1997). 
Respiratory distress and pulmonary hypoplasia are known malicious 
associations in neonates with severe PUV (Yohannes and Hanna 2002, Hodges 
et	al.	2009).	In	this	study,	pneumothorax	was	used	as	the	indicator	of	respiratory	
symptoms	because	it	was	recorded	well	throughout	the	series.	Pneumothorax	was	
seen	to	accompany	poor	kidney	outcome.	Ten	of	the	patients	had	pneumothorax	
at presentation, and more than half of them progressed to ESRD.
In our follow-up study, bilateral VUR constituted a poor prognostic factor for 
overall renal function.  However, unilateral VUR and urinomas had no impact 
on renal prognosis. VUR has been considered to be a risk for renal malfunction 
in some (Parkhouse et al. 1988, Roth et al. 2001, Oliveira et al. 2002, Ghanem et 
al. 2004) but not all reports (DeFoor et al. 2008, Kousidis et al. 2008).  Kidneys 
with VUR was observed to have reduced function in PUV patients primarily. By 
contrast, urinomas and unilateral VUR at presentation have been suggested to 
preserve renal function through a pop-off mechanism (Claahsen-van der Grinten 
et	al.	2002,	Oliveira	et	al.	2002,	Wells	2010).	Our	experience	does	not	provide	
support for this pop-off theory, in accord with some earlier reports (Patil et al. 
2003, Kleppe et al. 2006).
Dysfunction of the lower urinary tract is known to be common in PUV patients, 
and prompt management has been deemed crucial (Glassberg 2001).   Correct 
treatment may also reduce infection rates, although this aspect has not been 
thoroughly	clarified.	Urinary	tract	dysfunction	and	urinary	incontinence	have	
been suggested to predict poor renal function in PUV patients in some (Parkhouse 
et al. 1988, Lopez Pereira et al. 2002, Holmdahl and Sillén 2005, DeFoor et al. 
2008) but not all reports (Kousidis et al. 2008, Sarhan et al. 2008).  In the present 
study, recurrent UTIs were associated with poor outcome and impairment of renal 
function.	This	finding	is	in	agreement	with	some	earlier	observations	(Denes	
et al. 1997, Roth et al. 2001, Holmdahl and Sillén 2005).  In our study, urinary 
incontinence	after	the	age	of	five	years	was	common	(36%),	but	was	not	found	to	
indicate later renal failure.  In the early series, incontinence or its quality was not, 
however,	always	registered,	and	thus,	potential	reporting	bias	cannot	be	excluded.	
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CONCLUSIONS
Early features and late follow-up of patients with PUV during the 51-year period 
(1953-2003) were assessed in this study. Patient characteristics, presentation, 
associated anomalies, surgical management, early and late renal function and 
causes of death were sought. In addition, a cohort of infant patients from 1994 to 
2007 was analysed for early bladder function.
The main conclusions of the study are as follows:
1.   Posterior urethral valves often lead to ESRD with age. In the mid-thirties, the 
risk subsided in this study. Early presentation, poor primary renal function, 
pneumothorax	perinatally	as	well	as	VUR	bilaterally	and	recurrent	UTIs	
during childhood carry a risk for deterioration of renal function and ESRD. 
These risk factors should be recognized, proper management initiated and 
follow-up	extended	throughout	childhood	to	adulthood.
2.   The incidence of VUR in PUV patients at the time of presentation is high, 64% 
in the present study. Bilateral VUR is often accompanied by reduced overall 
kidney	function.	The	kidneys	of	refluxing	units	seem	to	have	worse	primary	
function than the contralateral kidneys. 
 Spontaneous resolution of VUR was observed to occur at a median of 1.28 
years after abolition of valves, more rapidly in unilateral than bilateral cases. 
Antireflux	surgery	is	most	often	not	justified.	
3.  The incidence of cryptorchidism is 16-fold higher and the incidence of 
inguinal hernia 7-fold higher in PUV patients than in the normal population. 
Cryptorchidism and inguinal hernias are more common in patients with severe 
PUV. The underlying pathophysiological mechanisms remain unclear. 
4.  High voiding pressures were seen in infants around the ablation of valves. 
However,	maximal	voiding	pressures	were	similar	in	an	institutional	control	
group and in male infant groups with different aetiologies according to 
previous reports. In our study, no correlation between high voiding pressures 
and poor primary kidney function was observed. The voiding pressures were 
registered to decrease slowly during the months following the release of the 
valvular obstruction. 
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CONCLUSIONS
5.  The current incidence of urinomas in PUV patients is presumably close to 
15%.  The renal function is similar in PUV patients with or without urinoma 
as well as in cases with perirenal urinoma and urine ascites. The abolition of 
valves	in	asymptomatic	cases	is	probably	the	only	justified	procedure	in	PUV	
patients with urinoma.
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